Other disorders of breast

N14_BREASTDISOTH

breast disease: A disease involving the breast.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule only females	293218
2. Check conditions None	293218
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N64 Hospital discharge: ICD-9 — 611[2-9] Hospital discharge: ICD-8 — 611[2-9] Hospital discharge: excluded ICD-9 — 6117B Cause of death: ICD-10 — N64 Cause of death: ICD-9 — 611[2-9] Cause of death: ICD-8 — 611[2-9] Cause of death: excluded ICD-9 — 6117B 2 out of 7 registries used, show all original rules.	5569
4. Check minimum number of events None	5569
5. Include endpoints N14_GALACTORRHEA	5611
6. Filter based on genotype QC (FinnGen only)	5371

Control definitions (FinnGen only)

Control exclude: N14_BREAST

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N60-N64
Name in latin: Aliae morbositates mammae

NAME	N14_BREASTDISOTH
CONTROL_EXCLUDE	N14_BREAST
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE	N14_GALACTORRHEA
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N64
HD_ICD_9	611[2-9]
HD_ICD_8	611[2-9]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	6117B
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N64
COD_ICD_9	611[2-9]
COD_ICD_8	611[2-9]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	6117B
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of breast based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Galactorrhea

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	30304	30304	-
Only index persons	28891	28891	-
Unadjusted period prevalence (%)
Whole population	0.87	0.87	-
Only index persons	1.06	1.06	-
Median age at first event (years)
Whole population	-	45.19	-
Only index persons	-	44.88	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5371	5371	-
Unadjusted period prevalence (%)	1.91	1.91	-
Median age at first event (years)	48.14	48.14	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5611: Matched controls
56110

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D24

ICD-10 Finland

Benign neoplasm of breast

9.2

315.7

394

455

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

7.9

307.9

439

596

N64.4

ICD-10 Finland

Mastodynia

13.7

307.7

1192

1081

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

20.1

307.7

622

346

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

59.6

307.7

373

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

11.1

307.7

375

361

N64.8

ICD-10 Finland

Other specified disorders of breast

83.2

307.7

528

N64.9

ICD-10 Finland

Disorder of breast, unspecified

128.5

307.7

1188

117

HA1AA

NOMESCO Finland

X-ray mammography

4.5

307.7

1174

3091

HA5CB

NOMESCO Finland

Galactography

180.7

307.7

192

N63

ICD-10 Finland

Unspecified lump in breast

7.8

307.7

1096

1694

N62

ICD-10 Finland

Hypertrophy of breast

87.4

307.7

368

HAB99

NOMESCO Finland

Other partial excision of mammary gland

8.3

307.7

473

615

N64.5

ICD-10 Finland

Other signs and symptoms in breast

85.5

307.7

2299

452

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

8.1

307.7

1542

2511

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.6

304.3

452

643

N61

ICD-10 Finland

Inflammatory disorders of breast

8.5

289.2

387

487

9729

FHL

Other measure in this category

81.1

282.2

150

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

8.7

272.6

357

437

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

23.5

254.7

184

HAB20

NOMESCO Finland

Excision of lactiferous duct

485.9

236.0

234

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

16.0

188.6

162

104

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

6.3

188.5

328

548

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

10.7

185.6

204

197

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

18.6

181.9

145

61199

ICD-8 Finland

Other diseases of breast, Other

+∞

167.5

160

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

32.4

158.3

102

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

4.0

152.1

462

1233

HAE99

NOMESCO Finland

Other reconstruction of breast

10.5

147.3

164

161

X21

ICPC

Breast sympt/compl female other

5.1

144.2

311

633

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

215.6

142.6

147

HAB40

NOMESCO Finland

Wedge excision of mammary gland

3.3

135.9

571

1884

6114A

ICD-9 Finland

Other disorders of breast, Atrophy of breast

+∞

133.9

128

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

24.5

132.7

N64.2

ICD-10 Finland

Atrophy of breast

334.9

131.1

132

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

4.9

130.4

294

621

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

6.8

124.3

197

298

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

20.8

121.6

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

5.0

118.9

266

558

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

5.3

117.2

243

477

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

4.0

112.7

331

859

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

6.1

112.6

198

333

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

6.5

111.2

184

291

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

5.6

109.5

212

391

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

5.2

105.6

221

437

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

11.3

103.0

108

N60.0

ICD-10 Finland

Solitary cyst of breast

15.6

102.6

Q83.8

ICD-10 Finland

Other congenital malformations of breast

17.3

99.8

HAC20

NOMESCO Finland

Total mastectomy

3.2

99.7

410

1329

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

99.5

1403

8019

9702

FHL

Breast exploration and possible tumor removal

7.8

97.2

135

176

HAD40

NOMESCO Finland

Mastopexy

9.1

95.3

117

131

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.7

93.4

554

2198

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

14.1

89.5

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

5.2

87.4

183

362

61191

ICD-8 Finland

Other diseases of breast, Fibrosis mammae

+∞

82.5

115

Kela drug reimbursment

Breast cancer

2.3

82.2

743

3564

PJA12

NOMESCO Finland

Sentinel node biopsy

2.3

81.3

690

3222

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.8

80.9

128

193

N60.2

ICD-10 Finland

Fibroadenosis of breast

13.8

76.7

HAD99

NOMESCO Finland

Other plastic operation on breast

8.3

76.1

100

122

HAA10

NOMESCO Finland

Biopsy of mammary gland

8.5

73.8

113

N60.8

ICD-10 Finland

Other benign mammary dysplasias

253.5

73.5

TQW20

NOMESCO Finland

Tatoe

5.5

72.3

142

265

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.7

71.7

417

1632

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

7.2

70.2

105

149

C50.99

ICD-10 Finland

Breast, unspecified

3.3

68.2

273

868

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

10.7

68.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

67.7

2316

16805

J02AC01

ATC

fluconazole; systemic

1.6

67.2

2964

22883

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

6.3

66.2

112

181

N64

ICD-10 Finland

Other disorders of breast

12.1

66.0

HA1AE, ,

SPAT

3.0

65.8

310

1084

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

23.7

65.4

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

27.7

64.8

61198

ICD-8 Finland

Other diseases of breast, Alii definita

+∞

63.7

J01DB01

ATC

cefalexin; oral

1.9

63.4

4707

41275

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

8.6

61.9

N60.4

ICD-10 Finland

Mammary duct ectasia

161.8

61.0

HA1RA, ,

SPAT

2.4

58.7

419

1805

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

57.9

1677

11558

N64.0

ICD-10 Finland

Fissure and fistula of nipple

151.6

57.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

56.9

2124

15552

9703

FHL

Breast resection

6.7

55.1

131

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.7

55.0

320

1250

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

11.3

54.4

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

7.5

53.8

104

HAD00

NOMESCO Finland

Augmentation mammoplasty

19.2

53.6

X18

ICPC

Breast pain female

3.6

52.9

175

492

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.7

52.9

124

270

X19

ICPC

Breast lump/mass female

3.4

50.3

189

577

QBJ00

NOMESCO Finland

Liposuction in trunk

7.1

50.3

109

N64.1

ICD-10 Finland

Fat necrosis of breast

+∞

50.1

6118X

ICD-9 Finland

Other disorders of breast, Other specified disorders of breast

+∞

49.0

ZXA05

NOMESCO Finland

Left side

1.6

48.4

1248

8292

6119X

ICD-9 Finland

Other disorders of breast, Unspecified breast disorder

+∞

46.9

ZZR10

NOMESCO Finland

Flap of skin and muscle

5.4

46.3

170

2531A

ICD-9 Finland

Disorders of the pituitary gland and its hypothalamic control, Other and unspecified anterior pituitary hyperfunction[HYPERPROLACTINAEMIA]

+∞

45.9

L02BA01

ATC

tamoxifen; oral

2.4

45.6

341

1496

A02BC02

ATC

pantoprazole; systemic

1.5

45.6

3726

31701

N02AX02

ATC

tramadol; systemic, rectal

1.5

44.8

2169

16567

A02BC05

ATC

esomeprazole; systemic

1.5

43.9

2285

17695

61190

ICD-8 Finland

Other diseases of breast, Atrophia mammae

+∞

43.8

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

3.6

43.7

148

423

C50

ICD-10 Finland

Malignant neoplasm of breast

2.8

42.4

217

793

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

42.2

1328

9214

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

42.1

1401

9844

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

41.4

1490

10648

R51.80

ICD-10 Finland

Headache

1.6

40.9

1002

6537

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.1

40.8

177

590

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

8.1

40.5

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

40.2

1867

14059

C07AA05

ATC

propranolol; systemic

1.6

40.0

1265

8771

N02BE01

ATC

paracetamol; systemic, rectal

1.8

39.5

4987

45896

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.4

39.5

143

427

P01AB01

ATC

metronidazole; oral, rectal

1.5

39.3

2451

19523

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

39.3

510

2764

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

2.8

39.0

203

748

E22.1

ICD-10 Finland

Hyperprolactinaemia

4.6

38.7

199

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

37.9

1619

11957

M03BX02

ATC

tizanidine; oral

1.5

37.8

3551

30430

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.7

37.5

212

815

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.1

37.2

366

1796

ZXA00

NOMESCO Finland

Right side

1.5

37.1

1280

9027

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

36.6

1295

9181

N05BA04

ATC

oxazepam; oral

1.5

36.6

1497

10943

N03AX16

ATC

[U] pregabalin

1.5

36.2

1245

8766

Z2221

NOMESCO Finland

Medical doctor

1.5

35.5

1531

11299

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

5.8

35.4

114

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

2.1

35.4

361

1794

J01FA10

ATC

azithromycin; systemic

1.4

34.7

3406

29183

M79.6

ICD-10 Finland

Pain in limb

1.4

34.3

2382

19188

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

34.2

740

4657

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

34.1

1455

10697

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

5.6

33.6

113

J01MA02

ATC

ciprofloxacin; systemic

1.4

33.3

1822

14038

E0000UV, ,

ATC

1.4

32.8

2358

19062

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

5.0

32.6

138

ZXD20

NOMESCO Finland

Day surgery

1.7

32.5

718

4540

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

32.3

564

3343

L02BG04

ATC

letrozole; oral

1.8

32.1

528

3076

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

7.3

30.9

J01DA01

ATC

[U] cefalexin

1.4

30.8

3371

29119

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.0

30.7

139

475

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

+∞

30.2

61000

ICD-8 Finland

Chronic cystic disease of breast, Fibroadenomatosis mammae

+∞

30.2

G44.2

ICD-10 Finland

Tension-type headache

1.6

30.1

879

5940

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

29.9

1873

14717

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

29.8

1052

7412

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

34.8

29.6

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

+∞

29.2

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

5.9

29.1

R4110

NOMESCO Finland

Physiotherapy

1.4

28.9

1370

10228

M25.5

ICD-10 Finland

Pain in joint

1.4

28.8

1865

14714

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

28.7

936

6479

HAD20

NOMESCO Finland

Liposuction of breast

10.7

28.6

M54.5

ICD-10 Finland

Low back pain

1.4

28.5

2008

16064

61099

ICD-8 Finland

Chronic cystic disease of breast, Unspecified

+∞

28.1

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

6.1

27.9

ZXA10

NOMESCO Finland

Bilateral

1.5

27.8

891

6139

N06AB04

ATC

citalopram; systemic

1.5

27.7

1174

8567

N05CD07

ATC

temazepam; oral

1.7

27.6

515

3106

S18

ICPC

Laceration/cut

1.4

27.3

2179

17752

A02BC01

ATC

omeprazole; systemic

1.4

27.3

1397

10559

N76.0

ICD-10 Finland

Acute vaginitis

1.7

27.3

495

2963

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.6

27.2

798

5388

J01AA02

ATC

doxycycline; systemic

1.4

27.1

4237

38394

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

26.7

1015

7242

Z71.8

ICD-10 Finland

Other specified counselling

1.4

26.7

1720

13518

J01FF01

ATC

clindamycin; systemic

1.4

26.5

1355

10229

N06AX21

ATC

duloxetine; oral

1.6

26.4

695

4575

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

26.4

688

4521

G02CB01

ATC

bromocriptine; systemic

2.6

26.2

154

605

R06.0

ICD-10 Finland

Dyspnoea

1.4

25.9

1287

9657

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

25.9

3285

28651

J01MA12

ATC

levofloxacin; systemic

1.5

25.5

782

5328

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

25.4

2826

24134

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.7

25.3

479

2898

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

25.1

367

2059

R03AC02

ATC

salbutamol; inhalant

1.3

25.1

3074

26612

K30

ICD-10 Finland

Functional dyspepsia

1.6

25.0

651

4271

M01AE02

ATC

naproxen; oral, rectal

1.3

25.0

3140

27276

R01AD09

ATC

mometasone; nasal

1.3

24.9

2632

22278

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

24.8

559

3543

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

24.7

916

6492

Z3226

NOMESCO Finland

Physiotherapist

1.5

24.7

891

6280

UJF32

NOMESCO Finland

Coloscopy

1.4

24.7

1219

9127

R07.3

ICD-10 Finland

Other chest pain

1.7

24.7

508

3144

O92.6

ICD-10 Finland

Galactorrhoea

7.8

24.6

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

5.3

24.6

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

24.6

2879

24724

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

24.5

1894

15284

N05CF01

ATC

zopiclone; oral

1.4

24.4

1584

12430

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

24.3

917

6523

A02BC03

ATC

lansoprazole; oral

1.4

24.2

1425

10999

M79.1

ICD-10 Finland

Myalgia

1.5

24.1

835

5833

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

24.1

531

3344

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

24.0

2062

16895

N05BA12

ATC

alprazolam; oral

1.6

24.0

542

3435

N06AX11

ATC

mirtazapine; oral

1.4

24.0

1807

14511

R53

ICD-10 Finland

Malaise and fatigue

1.4

23.9

1267

9598

J02AC02

ATC

itraconazole; systemic

1.5

23.9

1004

7292

N06AX16

ATC

venlafaxine; oral

1.5

23.8

833

5832

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

7.0

23.7

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

5.5

23.6

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.4

23.6

160

672

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

23.4

309

1680

D22

ICD-10 Finland

Melanocytic naevi

1.9

23.3

324

1791

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

23.1

2152

17815

A02BA02

ATC

ranitidine; systemic

1.5

23.0

895

6397

M01AH05

ATC

etoricoxib; oral

1.3

23.0

3346

29520

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

22.9

1150

8619

Z3231

NOMESCO Finland

Registered nurse

1.4

22.8

1266

9658

L03

ICPC

Low back symptom/complaint

1.4

22.7

1547

12206

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

2.7

22.6

122

459

J01CA08

ATC

pivmecillinam; oral

1.3

22.6

2970

25799

R52.9

ICD-10 Finland

Pain, unspecified

1.6

22.5

519

3303

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

3.4

22.5

242

J01FA09

ATC

clarithromycin; systemic

1.4

22.3

1723

13852

R01AD08

ATC

fluticasone; nasal

1.4

22.1

1604

12766

9722

FHL

Reduction plastic and possible mamilla transposition

35.2

22.0

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

3.1

22.0

286

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

21.8

521

3347

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

21.7

334

1903

HA3RT

NOMESCO Finland

Coagulation of mammary neoplasm under radiological guidance

115.5

21.6

X76

ICPC

Malignant neoplasm breast female

2.4

21.5

148

626

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

21.5

2246

18845

ZXE00

NOMESCO Finland

One hour or less

1.3

21.4

2005

16556

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

2.6

21.4

124

484

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

21.3

5048

47818

UKC02

NOMESCO Finland

Cystoscopy

1.6

21.1

482

3059

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

4.9

21.0

R01AD58

ATC

fluticasone, combinations; nasal

1.4

21.0

1442

11366

N03AX12

ATC

[U] gabapentin; oral

1.5

20.7

824

5907

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.2

20.7

167

758

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

20.6

1129

8572

N06AB10

ATC

escitalopram; oral

1.4

20.6

1174

8973

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

20.6

1274

9869

G01AA10

ATC

clindamycin; vaginal

1.4

20.6

1084

8176

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.7

20.6

112

424

R00.2

ICD-10 Finland

Palpitations

1.6

20.5

467

2961

G02CB03

ATC

cabergoline; oral

4.4

20.5

117

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.0

20.5

210

1045

WX402

NOMESCO Finland

General anaesthesia

1.4

20.5

1052

7897

XQ800

NOMESCO Finland

Prick test

1.6

20.4

453

2855

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

20.0

1497

11935

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.2

20.0

240

N05BA01

ATC

diazepam; systemic, rectal

1.5

19.9

622

4243

HAA00

NOMESCO Finland

Incision of mammary gland

57.7

19.9

L01

ICPC

Neck symptom/complaint

1.4

19.8

896

6575

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

19.8

1987

16524

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

19.8

471

3021

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

5.1

19.7

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.7

19.7

103

382

K07.60

ICD-10 Finland

Snapping jaw

1.7

19.7

346

2050

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

8.2

19.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

2.7

19.6

106

400

HA1SA

NOMESCO Finland

Expansion mammography

4.6

19.6

101

N06AB06

ATC

sertraline; oral

1.5

19.5

633

4354

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

19.2

599

4084

N05CF02

ATC

zolpidem; oral

1.4

19.0

940

7003

R01AD12

ATC

fluticasone furoate; nasal

1.3

18.9

1811

14934

D01

ICPC

Abdominal pain/cramps general

1.5

18.9

654

4557

A02BC04

ATC

rabeprazole; oral

1.6

18.8

473

3071

R05

ICD-10 Finland

Cough

1.4

18.7

1101

8442

R42

ICD-10 Finland

Dizziness and giddiness

1.4

18.6

1108

8510

THA00

NOMESCO Finland

Needle biopsy of mamilla

20.9

18.6

N60.3

ICD-10 Finland

Fibrosclerosis of breast

190.6

18.5

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

18.3

949

7121

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

18.3

666

4685

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

3.9

18.3

137

R83

ICPC

Respiratory infection other

1.3

18.2

1453

11669

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

18.1

399

2508

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

3.6

18.1

170

HA1BA

NOMESCO Finland

Extensive X-ray mammography

3.7

18.0

152

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

17.9

3826

34907

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

17.9

663

4678

L04

ICPC

Chest symptom/complaint

1.7

17.9

323

1927

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

17.9

2335

20018

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

17.8

454

2957

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

17.8

1759

14541

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

17.8

537

3632

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

17.8

276

1578

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

17.8

386

2419

J01FA06

ATC

roxithromycin; oral

1.3

17.7

2080

17586

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

17.7

1044

8002

K59.0

ICD-10 Finland

Constipation

1.8

17.6

268

1523

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

6.3

17.5

Q83.1

ICD-10 Finland

Accessory breast

6.3

17.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

17.5

577

3976

C07AB07

ATC

bisoprolol; oral

1.3

17.5

2016

16996

D05.0

ICD-10 Finland

Lobular carcinoma in situ

7.1

17.4

Z31.5

ICD-10 Finland

Genetic counselling

1.7

17.3

328

1983

M01AB05

ATC

diclofenac; systemic, rectal

1.3

17.3

3459

31210

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

17.3

308

1832

D07AC01

ATC

betamethasone; topical

1.3

17.2

1785

14840

J05AB11

ATC

valaciclovir; oral

1.4

17.2

786

5769

Z01.2

ICD-10 Finland

Dental examination

1.3

17.1

2491

21604

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

2.5

17.1

102

405

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

4.1

17.0

113

S29

ICPC

Skin symptom/complaint other

1.4

17.0

936

7090

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

17.0

901

6782

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

16.8

1190

9370

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

16.8

827

6146

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

16.7

274

1591

9724

FHL

Breast augmentation or reconstruction with own tissue

15.1

16.6

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

16.4

287

1699

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

4.0

16.4

112

S82

ICPC

Naevus/mole

1.4

16.3

696

5039

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

16.3

397

2557

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

16.2

520

3561

R06AE07

ATC

cetirizine; oral

1.3

16.2

2524

22022

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

16.1

1653

13691

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

16.0

528

3637

X58

ICD-10 Finland

Exposure to other specified factors

1.5

16.0

614

4358

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

15.9

358

2263

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

15.8

834

6268

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.5

15.8

441

2933

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.2

15.7

132

610

D07AD01

ATC

clobetasol; topical

1.4

15.7

860

6504

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

15.6

432

2865

6117E

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[RINTARAUHASEN POIKKEAVA ERITE]

+∞

15.6

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

15.6

429

2842

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

15.6

356

2259

V500A

ICD-9 Finland

Elective surgery for purposes other than remedying health states, Hair transplant

5.6

15.5

ZZS55

NOMESCO Finland

Distension of tissue expander

19.2

15.5

A03FA02

ATC

cisapride; oral, rectal

1.6

15.5

349

2207

HAD45

NOMESCO Finland

Eversion of mamilla

160.4

15.5

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

15.4

630

4525

D02

ICPC

Abdominal pain epigastric

1.6

15.4

337

2116

WX002

NOMESCO Finland

Sedation and analgesia

1.4

15.3

879

6691

SBB10

NOMESCO Finland

Dental impressions

1.6

15.3

333

2087

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

15.3

1563

12925

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

15.3

209

1150

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

15.2

1195

9538

H02AB06

ATC

prednisolone; systemic

1.3

15.2

2359

20521

M03AX01

ATC

botulinum toxin; parenteral

2.5

15.1

357

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

15.1

404

2660

U02

ICPC

Urinary frequency/urgency

1.4

15.1

817

6161

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

15.1

414

2742

Z00.8

ICD-10 Finland

Other general examinations

1.6

15.0

366

2358

B02AA02

ATC

tranexamic acid; systemic

1.4

14.8

949

7350

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

14.8

651

4739

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

14.7

173

906

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

14.7

684

5027

S04

ICPC

Lump/swelling localized

1.5

14.7

516

3600

L03AA13

ATC

pegfilgrastim; parenteral

1.8

14.6

236

1365

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

3.8

14.6

117

6110A

ICD-9 Finland

Other disorders of breast, Inflammatory disease of breast

+∞

14.6

6116A

ICD-9 Finland

Other disorders of breast, Galactorrhoea not associated with childbirth

+∞

14.6

Z00.0

ICD-10 Finland

General medical examination

1.4

14.5

886

6807

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

3.6

14.5

127

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

14.5

502

3492

X26

ICPC

Fear of breast cancer female

3.2

14.5

171

J01EA01

ATC

trimethoprim; systemic

1.3

14.4

1572

13084

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

2.8

14.4

262

N06AB05

ATC

paroxetine; oral

1.6

14.3

306

1909

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

14.3

453

3092

N06AB03

ATC

fluoxetine; oral

1.4

14.3

644

4703

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.8

14.3

201

1116

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

14.2

315

1983

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

14.2

317

2000

HA1HA

NOMESCO Finland

Tomosynthesis mammography

3.6

14.2

129

M01AH01

ATC

celecoxib; oral

1.4

14.2

873

6715

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

14.2

1506

12493

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

14.1

522

3676

D06

ICPC

Abdominal pain localized other

1.5

14.1

481

3334

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

3.4

14.1

144

K08.80

ICD-10 Finland

Toothache NOS

1.5

14.0

479

3325

Z01.7

ICD-10 Finland

Laboratory examination

1.4

13.9

711

5305

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

13.9

190

1045

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

13.9

660

4865

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

13.9

110

497

R52.2

ICD-10 Finland

Other chronic pain

1.8

13.8

189

1040

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

6.0

13.8

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

13.8

145

731

H02AB07

ATC

prednisone; oral

1.4

13.6

649

4785

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.5

13.6

495

3474

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

5.1

13.6

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

13.6

874

6765

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

13.6

280

1733

61101

ICD-8 Finland

Other diseases of breast, Abscessus mammae

+∞

13.5

6117A

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[MASTODYNIA]

+∞

13.5

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

3.4

13.5

143

R74

ICPC

Upper respiratory infection acute

1.3

13.5

1830

15609

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.9

13.5

182

998

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.5

13.5

494

3473

N30.0

ICD-10 Finland

Acute cystitis

1.3

13.5

968

7614

XKD00

NOMESCO Finland

Uroflowmetry

1.8

13.5

203

1152

D19

ICPC

Teeth/gum symptom/complaint

1.3

13.3

1477

12298

L90.6

ICD-10 Finland

Striae atrophicae

5.3

13.2

J01DA09

ATC

[U] cefadroxil

1.3

13.2

1311

10768

HAC25

NOMESCO Finland

Radical mastectomy

4.2

13.1

X20

ICPC

Nipple symptom/complaint female

4.0

13.1

U01

ICPC

Dysuria/painful urination

1.5

13.1

466

3257

S06.0

ICD-10 Finland

Concussion

1.5

13.0

476

3344

N01

ICPC

Headache

1.4

13.0

606

4454

G03DB01

ATC

dydrogesterone; oral

1.3

12.9

891

6964

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.6

12.9

306

1960

M02AA07

ATC

piroxicam; topical

1.3

12.9

1715

14582

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

12.9

623

4606

N05AH04

ATC

quetiapine; oral

1.3

12.8

834

6461

J05AB01

ATC

aciclovir; systemic

1.3

12.8

1159

9403

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

12.8

1424

11856

R60.0

ICD-10 Finland

Localized oedema

1.4

12.7

531

3824

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

12.7

1697

14425

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

12.7

624

4626

R03DC03

ATC

montelukast; oral

1.3

12.6

904

7103

WZC30

NOMESCO Finland

Teaching

1.4

12.5

657

4920

A99

ICPC

Disease/condition unspecnature/site

1.5

12.5

418

2884

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

3.0

12.5

176

R21

ICPC

Throat symptom/complaint

1.3

12.5

1185

9663

6111A

ICD-9 Finland

Other disorders of breast, Hypertrophy of breast

+∞

12.5

6117D

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[SUBINVOLUTIO MAMMAE POST PARTUM]

+∞

12.5

L02BG03

ATC

anastrozole; oral

2.2

12.5

101

461

R03BA05

ATC

fluticasone; inhalant

1.3

12.5

921

7265

J01CA04

ATC

amoxicillin; systemic

1.3

12.5

4467

42211

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

12.4

2085

18169

R06AX22

ATC

ebastine; oral

1.3

12.4

949

7524

A01AB09

ATC

miconazole; local oral

1.5

12.3

420

2910

L02BG06

ATC

exemestane; oral

2.1

12.3

115

556

E000001, ,

ATC

1.3

12.3

994

7938

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

1.8

12.3

168

926

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

12.3

335

2216

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

14.3

12.2

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

3.8

12.2

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.4

12.2

541

3936

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.8

12.2

196

1133

XF402

NOMESCO Finland

ECG with work load test

1.5

12.1

388

2654

M54.2

ICD-10 Finland

Cervicalgia

1.5

12.1

388

2654

M01AX17

ATC

nimesulide; oral

1.3

12.1

1070

8646

N04BC06

ATC

cabergoline; oral

3.5

12.1

114

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

2.0

12.1

135

697

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

12.0

359

2421

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

12.0

2880

25998

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

12.0

2201

19335

HAB30

NOMESCO Finland

Excision of mamilla or areola

21.3

12.0

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

12.0

134

692

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

11.9

193

1120

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

11.9

1135

9261

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

2.9

11.8

182

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

11.8

671

5090

N39.3

ICD-10 Finland

Stress incontinence

1.4

11.8

459

3264

R05

ICPC

Cough

1.3

11.8

1236

10201

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

3.4

11.8

121

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

1.9

11.7

141

746

N80.0

ICD-10 Finland

Endometriosis of uterus

1.9

11.7

147

789

L29

ICPC

Musculoskeletal sympt/complt other

1.5

11.7

418

2925

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

11.7

248

1547

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

2.5

11.7

292

F29

ICPC

Eye symptom/complaint other

1.4

11.6

461

3289

J01AA07

ATC

tetracycline; systemic

1.3

11.6

778

6050

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

11.6

762

5908

K04

ICPC

Palpitations/awareness of heart

1.6

11.5

267

1701

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

11.5

274

1757

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

11.5

3891

36300

L02

ICPC

Back symptom/complaint

1.4

11.4

524

3835

J01CF02

ATC

cloxacillin; systemic

2.3

11.4

369

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

11.4

1998

17442

N06AX26

ATC

vortioxetine; oral

1.5

11.4

358

2442

A04

ICPC

Weakness/tiredness general

1.3

11.3

703

5402

R30.0

ICD-10 Finland

Dysuria

1.7

11.3

199

1181

H02AB02

ATC

dexamethasone; systemic

1.4

11.3

520

3808

C01CA24

ATC

epinephrine; parenteral

1.5

11.3

336

2264

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

11.3

553

4093

J01FA01

ATC

erythromycin; systemic

1.3

11.3

738

5715

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

11.3

157

871

R51

ICD-10 Finland

Headache

1.5

11.3

305

2015

F13

ICPC

Eye sensation abnormal

1.9

11.2

133

702

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

11.1

497

3622

G01AF05

ATC

econazole; vaginal

1.4

11.1

519

3811

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

11.1

1799

15567

U71

ICPC

Cystitis/urinary infection other

1.5

11.1

402

2821

P01

ICPC

Feeling anxious/nervous/tense

1.3

11.1

674

5165

J01MA06

ATC

norfloxacin; oral

1.3

11.0

684

5254

L12

ICPC

Hand/finger symptom/complaint

1.3

11.0

801

6295

L15

ICPC

Knee symptom/complaint

1.3

11.0

1183

9777

R50.9

ICD-10 Finland

Fever, unspecified

1.4

11.0

613

4632

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

11.0

2441

21797

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

11.0

262

1682

G01AF01

ATC

metronidazole; vaginal

1.4

10.9

622

4718

L13

ICPC

Hip symptom/complaint

1.3

10.9

886

7072

N30

ICD-10 Finland

Cystitis

1.4

10.8

489

3570

B01AB05

ATC

enoxaparin; parenteral

1.2

10.8

1444

12234

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

15.5

10.8

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

10.8

413

2928

GD1AA, ,

SPAT

1.4

10.7

558

4170

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

10.7

177

1033

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

10.7

206

1254

R31

ICD-10 Finland

Unspecified haematuria

1.6

10.7

242

1534

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

10.7

387

2715

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

10.6

234

1473

R30.1

ICD-10 Finland

Vesical tenesmus

2.1

10.5

100

487

L17

ICPC

Foot/toe symptom/complaint

1.2

10.5

1393

11785

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

10.5

199

1206

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.6

10.5

242

1541

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.6

10.5

218

R03BA02

ATC

budesonide; inhalant

1.3

10.4

901

7244

N17

ICPC

Vertigo/dizziness

1.4

10.4

563

4233

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

10.4

389

2744

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

10.4

892

7170

A06AD11

ATC

lactulose; oral

1.4

10.3

526

3917

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

16.0

10.3

XKC03

NOMESCO Finland

Water cystometry

1.8

10.3

140

771

J01AA04

ATC

lymecycline; systemic

1.3

10.3

665

5138

21799

ICD-8 Finland

Benign neoplasm of breast

2.9

10.3

169

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

10.3

801

6355

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

10.2

332

2280

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

10.2

224

1411

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

10.1

168

982

N02CC03

ATC

zolmitriptan; nasal, oral

1.5

10.1

328

2251

N06AA09

ATC

amitriptyline; systemic

1.4

10.1

455

3320

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

3.3

10.1

113

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

10.1

311

2113

J20

ICD-10 Finland

Acute bronchitis

1.4

10.1

493

3648

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.7

10.0

190

1154

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

3.4

10.0

104

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

10.0

225

1426

PJW99

NOMESCO Finland

Other operation on lymphatic system

3.3

10.0

114

N06AX12

ATC

bupropion; oral

1.5

9.9

345

2402

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

9.8

756

5988

M79.7

ICD-10 Finland

Fibromyalgia

1.6

9.8

224

1425

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

9.7

226

1443

C09CA06

ATC

candesartan; oral

1.3

9.7

1083

8978

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

9.7

1117

9293

R06AX27

ATC

desloratadine; oral

1.2

9.7

1593

13764

A06AX04

ATC

linaclotide; oral

4.1

9.7

A11

ICPC

Chest pain NOS

1.5

9.7

331

2297

N02CC06

ATC

eletriptan; oral

1.6

9.7

212

1335

R07.0

ICD-10 Finland

Pain in throat

1.4

9.6

360

2541

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

9.6

112

588

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

9.6

431

3144

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

9.6

196

1213

D07AC13

ATC

mometasone; topical

1.2

9.6

1370

11670

G43

ICD-10 Finland

Migraine

1.5

9.6

312

2145

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

9.6

286

1932

G04BD08

ATC

solifenacin; oral

1.5

9.5

263

1746

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.3

9.5

608

4688

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

4.8

9.5

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

2.1

9.5

452

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

9.5

250

1642

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

2.8

9.5

160

G43.8

ICD-10 Finland

Other migraine

2.0

9.5

500

D11

ICPC

Diarrhoea

1.3

9.5

599

4612

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

9.4

601

4632

HA5CB, ,

SPAT

100.2

9.4

9705

FHL

Subcutaneous mastectomy

100.2

9.4

U07

ICPC

Urine symptom/complaint other

1.5

9.4

329

2293

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

9.4

173

1042

S21

ICPC

Skin texture symptom/complaint

1.3

9.4

626

4858

61001

ICD-8 Finland

Chronic cystic disease of breast, Cysta (cystis) mammae

+∞

9.4

R06AX13

ATC

loratadine; oral

1.3

9.3

805

6467

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

9.3

366

2607

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

9.3

152

886

1410

FHL

Laparoscopy

1.7

9.3

163

969

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

9.3

571

4381

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

9.2

253

1677

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.2

9.2

351

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

9.2

397

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

9.2

464

3453

K80

ICPC

Cardiac arrhythmia NOS

1.4

9.2

355

2523

C05AA08

ATC

fluocortolone; rectal, topical

1.3

9.1

602

4664

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

9.1

259

1731

G01AF02

ATC

clotrimazole; vaginal

1.6

9.1

216

1387

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

9.1

386

2790

N06AA12

ATC

doxepin; systemic

1.6

9.1

218

1404

R06AE09

ATC

levocetirizine; oral

1.3

9.1

746

5956

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.5

9.1

255

1701

H01

ICPC

Ear pain/earache

1.3

9.0

588

4548

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.1

9.0

375

C08DA01

ATC

verapamil; systemic

1.7

9.0

165

994

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

9.0

860

6998

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

9.0

191

1195

M70.6

ICD-10 Finland

Trochanteric bursitis

1.3

9.0

729

5811

G03DC02

ATC

norethisterone; oral

1.3

8.9

665

5241

UJH02

NOMESCO Finland

Anoscopy

1.6

8.9

186

1159

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

8.8

293

A01AB04

ATC

amphotericin B; local oral

1.6

8.8

201

1278

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

8.8

251

1678

A01

ICPC

Pain general/multiple sites

1.4

8.8

423

3120

TQW40

NOMESCO Finland

Remowal of suture of skin

1.5

8.8

295

2039

M01AH02

ATC

rofecoxib; oral

1.3

8.8

530

4051

H02AB04

ATC

methylprednisolone; systemic

1.3

8.8

680

5384

JN1AE, ,

SPAT

1.7

8.7

167

1017

R12

ICD-10 Finland

Heartburn

1.4

8.7

380

2759

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

8.7

160

965

A08

ICPC

Swelling

1.6

8.7

210

1355

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

8.7

162

981

A07AA02

ATC

nystatin; oral

1.5

8.7

255

1718

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

8.6

1029

8582

M54.8

ICD-10 Finland

Other dorsalgia

1.6

8.6

222

1452

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

8.6

2701

24673

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

8.6

381

2772

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

8.6

579

4497

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

3.2

8.6

104

KMAK, ,

NOMESCO Finland

1.2

8.5

2688

24561

ZSZ00

NOMESCO Finland

Primary repair operation

9.0

8.5

D23

ICD-10 Finland

Other benign neoplasms of skin

1.8

8.5

111

606

O91.2

ICD-10 Finland

Nonpurulent mastitis associated with childbirth

2.3

8.5

273

-1, ,

NOMESCO Finland

1.2

8.5

1624

14205

F45.0

ICD-10 Finland

Somatization disorder

3.2

8.5

100

N81.6

ICD-10 Finland

Rectocele

1.4

8.4

390

2860

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.4

8.4

438

3274

D06BB03

ATC

aciclovir; topical

1.5

8.4

239

1598

HA1AA, ,

SPAT

1.8

8.4

122

688

J01DA06

ATC

[U] cefuroxime

1.3

8.4

676

5380

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.1

8.4

339

SAA04

NOMESCO Finland

Special examination of mouth

1.5

8.4

229

1519

A06AC51

ATC

ispaghula, combinations; oral

1.5

8.4

225

1487

ULA02

NOMESCO Finland

Kolposcopy

1.3

8.4

620

4881

JN4BD

NOMESCO Finland

Extensive body CT

1.4

8.3

365

2651

6113A

ICD-9 Finland

Other disorders of breast, Fat necrosis of breast

+∞

8.3

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.5

8.3

234

1561

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

8.3

117

654

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1.6

8.3

185

1171

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.7

8.3

151

908

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.1

8.3

334

9721

FHL

Mamilla reconstruction or transposition

9.4

8.3

C10AA07

ATC

rosuvastatin; oral

1.2

8.2

1298

11140

9862

FHL

Facial skin shaping surgery (Faclift)

7.1

8.2

5702

FHL

Local lymph node removal (eg armpit, groin)

3.8

8.2

G04BD12

ATC

mirabegron; oral

1.4

8.2

456

3443

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.1

8.2

355

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

8.2

197

1269

N03AE01

ATC

clonazepam; systemic

1.5

8.2

246

1665

UJD02

NOMESCO Finland

Gastroscopy

1.6

8.1

184

1169

TAB00

NOMESCO Finland

Lumbar puncture

1.6

8.1

199

1288

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.5

8.1

280

1948

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.1

783

6372

A04AA01

ATC

ondansetron; systemic, rectal

1.4

8.1

372

2725

EMB10

NOMESCO Finland

Tonsillectomy

1.5

8.0

283

1978

D10AF01

ATC

clindamycin; topical

1.5

8.0

241

1632

K64.0

ICD-10 Finland

First degree haemorrhoids

1.9

8.0

518

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

8.0

254

1740

H57.1

ICD-10 Finland

Ocular pain

1.6

8.0

182

1160

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

7.9

244

1659

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.8

7.9

120

686

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.7

7.9

143

859

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

2.8

7.9

137

D07AA02

ATC

hydrocortisone; topical

1.3

7.9

647

5163

G03DA02

ATC

medroxyprogesterone; systemic

1.3

7.8

528

4102

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

7.8

415

3113

S01AA01

ATC

chloramphenicol; ophthalmic

1.5

7.8

228

1535

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.3

7.8

752

6119

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

7.8

3583

33654

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

7.8

1486

12976

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

7.8

1250

10740

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

9.4

7.8

L57.0

ICD-10 Finland

Actinic keratosis

1.4

7.8

353

2582

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

7.8

281

1974

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

7.8

133

788

A07DA03

ATC

loperamide; oral

1.7

7.7

127

743

A98

ICPC

Health maint/preventive medicine

1.6

7.7

5461

53727

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

7.7

238

1619

AA1BG, ,

SPAT

2.0

7.7

425

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.7

7.7

132

781

N05CB02

ATC

barbiturates in combination with other drugs

1.8

7.7

113

640

R01BA01

ATC

phenylpropanolamine; oral

1.5

7.7

253

1744

XQ802

NOMESCO Finland

Epicutan test

1.5

7.7

219

1467

A97

ICPC

No disease

1.3

7.7

783

6414

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

7.6

307

2198

AA1AD

NOMESCO Finland

CT of head and brain

1.2

7.6

1025

8652

G44.0

ICD-10 Finland

Cluster headache syndrome

2.3

7.6

248

R19.5

ICD-10 Finland

Other faecal abnormalities

2.0

7.6

421

L29.2

ICD-10 Finland

Pruritus vulvae

1.8

7.6

105

585

G01AF04

ATC

miconazole; vaginal

1.4

7.6

294

2092

G43.3

ICD-10 Finland

Complicated migraine

1.8

7.6

103

571

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

7.5

333

2424

K24

ICPC

Fear of heart disease

1.8

7.5

107

601

D07XC01

ATC

betamethasone; topical

1.3

7.5

455

3481

D10BA01

ATC

isotretinoin; oral

1.4

7.5

299

2138

D01AE16

ATC

amorolfine; topical

1.3

7.5

474

3650

K58

ICD-10 Finland

Irritable bowel syndrome

1.7

7.5

135

811

G04BD07

ATC

tolterodine; oral

1.6

7.5

189

1233

R03BA08

ATC

ciclesonide; inhalant

1.3

7.5

421

3186

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

7.5

906

7561

R13

ICD-10 Finland

Dysphagia

1.4

7.5

266

1863

9719

FHL

Other measure in this category

7.1

7.5

SPAT1153

SPAT

Removal of sutures

1.2

7.5

1338

11610

H92.0

ICD-10 Finland

Otalgia

1.4

7.4

299

2142

A05

ICPC

Feeling ill

1.4

7.4

281

1991

L57.4

ICD-10 Finland

Cutis laxa senilis

4.4

7.4

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.6

7.4

165

N02CC04

ATC

rizatriptan; oral

1.4

7.4

324

2356

D07AB08

ATC

desonide; topical

1.3

7.4

483

3737

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

1.9

7.4

419

L05

ICPC

Flank/axilla symptom/complaint

1.5

7.3

252

1753

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

7.3

270

1903

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

1.8

7.3

548

S20.2

ICD-10 Finland

Contusion of thorax

1.6

7.3

182

1184

D07CB01

ATC

triamcinolone and antibiotics; topical

1.9

7.3

448

K64.1

ICD-10 Finland

Second degree haemorrhoids

1.9

7.3

505

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

7.3

164

1042

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

7.3

378

2825

R35

ICD-10 Finland

Polyuria

1.5

7.3

189

1241

N03AX09

ATC

lamotrigine; oral

1.5

7.3

230

1574

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

7.3

579

4599

R32

ICD-10 Finland

Unspecified urinary incontinence

1.7

7.3

128

765

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

7.2

162

1028

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

7.2

249

1733

N93.0

ICD-10 Finland

Postcoital and contact bleeding

2.3

7.2

222

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

7.2

482

3740

F50.9

ICD-10 Finland

Eating disorder, unspecified

2.3

7.2

241

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

7.2

222

1512

A03

ICPC

Fever

1.2

7.2

803

6644

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.3

7.1

465

3595

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

7.1

1139

9772

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.7

7.1

111

641

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.7

7.1

132

800

A60

ICPC

General and Unspecified, Result test/procedure

1.5

7.1

184

1209

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

2.6

7.1

157

M77.4

ICD-10 Finland

Metatarsalgia

1.4

7.1

295

2127

N06AA10

ATC

nortriptyline; systemic

1.8

7.1

102

576

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.7

7.1

120

710

N03AX11

ATC

topiramate; oral

1.7

7.1

133

809

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.3

7.1

526

4143

M54

ICD-10 Finland

Dorsalgia

1.3

7.0

586

4681

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.0

1307

11370

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.9

7.0

490

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.6

7.0

153

967

S02

ICPC

Pruritus

1.6

6.9

151

954

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.6

6.9

160

1025

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.8

6.9

522

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.9

6.9

422

A02BA04

ATC

nizatidine; systemic

1.4

6.9

285

2053

J31.0

ICD-10 Finland

Chronic rhinitis

1.3

6.9

391

2965

ULC02

NOMESCO Finland

Hysteroscopy

1.4

6.9

296

2148

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

6.8

255

1804

N92.3

ICD-10 Finland

Ovulation bleeding

3.3

6.8

1413

FHL

Laparoscopy and other therapeutic procedure

1.6

6.8

133

817

S10

ICPC

Boil/carbuncle

1.5

6.8

220

1514

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.8

120

718

R04

ICPC

Breathing problem other

1.6

6.8

146

919

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.9

6.8

439

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

6.7

216

1484

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.0

6.7

335

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

1.7

6.7

126

766

A29

ICPC

General symptom/complaint other

1.3

6.7

503

3964

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

6.7

312

2293

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

6.7

205

1396

N80

ICD-10 Finland

Endometriosis

2.2

6.7

224

G50.1

ICD-10 Finland

Atypical facial pain

1.8

6.6

514

N06BA04

ATC

methylphenidate; oral

1.6

6.6

137

854

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

3.7

6.6

G04BD09

ATC

trospium; oral

1.7

6.6

106

618

S83.2

ICD-10 Finland

Tear of meniscus, current

1.4

6.6

244

1723

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

6.6

685

5619

J45

ICD-10 Finland

Asthma

1.3

6.6

495

3905

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.6

6.6

146

927

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

3.2

6.6

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

6.5

265

1902

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.6

6.5

161

1047

SFA00

NOMESCO Finland

Small restoration

1.3

6.5

634

5161

XQ899

NOMESCO Finland

Other assessment of skin

2.8

6.5

106

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.0

6.5

319

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

6.5

317

2349

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.7

6.5

122

743

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.5

6.5

186

1250

D16

ICPC

Rectal bleeding

1.8

6.5

518

Z50.1

ICD-10 Finland

Other physical therapy

1.5

6.5

210

1447

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.3

6.5

446

3478

O92.0

ICD-10 Finland

Retracted nipple associated with childbirth

6.2

6.5

C03DA01

ATC

spironolactone; oral

1.3

6.4

392

3004

9723

FHL

Reducing plastic mom

69.9

6.4

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

6.4

155

1003

M01AB51

ATC

indometacin, combinations; oral, rectal

1.9

6.4

390

NA2AA, ,

SPAT

2.5

6.4

159

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

6.4

509

4043

L08

ICPC

Shoulder symptom/complaint

1.2

6.4

964

8221

A04AA55

ATC

palonosetron, combinations; systemic

1.5

6.4

187

1263

L14

ICPC

Leg/thigh symptom/complaint

1.4

6.4

333

2495

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.7

6.3

100

581

H53.2

ICD-10 Finland

Diplopia

1.7

6.3

119

725

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

6.3

186

1258

X79

ICPC

Benign neoplasm breast female

9.2

6.3

R75

ICPC

Sinusitis acute/chronic

1.4

6.3

254

1824

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

6.3

135

851

61008

ICD-8 Finland

Chronic cystic disease of breast, Alia definita

+∞

6.2

K29

ICPC

Cardiovascular sympt/complt other

1.6

6.2

139

883

XF404

NOMESCO Finland

Ambulatory ECG

1.4

6.2

304

2252

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.4

6.2

241

1717

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

6.2

169

1123

21899

ICD-8 Finland

Uterine fibroma

1.5

6.2

178

1196

U13

ICPC

Bladder symptom/complaint other

1.6

6.2

128

798

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.1

6.2

244

G04BD01

ATC

emepronium; systemic

2.6

6.2

132

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.2

6.2

212

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

2.2

6.2

212

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.7

6.2

112

676

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

1.8

6.2

431

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

6.2

145

933

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.2

1943

17610

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

3.5

6.1

D02AE01

ATC

carbamide; topical

1.4

6.1

274

2001

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.1

372

2850

D01AC03

ATC

econazole; topical

1.5

6.1

202

1398

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

6.1

188

1283

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

6.1

1310

11522

L60.0

ICD-10 Finland

Ingrowing nail

1.5

6.1

189

1292

NA3BG, ,

SPAT

1.5

6.1

166

1105

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.5

6.1

182

1235

SDA03

NOMESCO Finland

Periodontal treatment

1.2

6.1

2029

18463

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

2.2

6.1

201

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

6.1

259

1878

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

6.0

659

5434

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

2.9

6.0

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

6.0

643

5289

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

6.0

486

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768793) Breast Pathology biopsy report

806

1468

6.24

307.65

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

3037

21014

1.97

130.82

2.3

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

2101

14904

1.65

66.94

2.2

2.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3008

23578

1.59

61.88

5.7

5.6

9.73

9.99

umol/l

0.90

2848

22213

(4035726) Immunohistochemistry procedure

760

4138

1.97

58.84

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1627

11192

1.64

56.31

2.2

2.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4194

36026

1.65

55.40

7.6

7.0

73.47

75.97

u/l

4.67

3968

33867

(3013707) Erythrocyte sedimentation rate by Westergren method

4188

36311

1.60

49.54

4.3

4.1

10.45

11.87

mm/h

13.40

3922

33779

(3002256) Pathology report gross observation

988

6240

1.71

46.21

1.3

1.2

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4928

44950

1.79

43.68

12.3

11.1

85.14

84.39

ml/min/173m2

1.71

4091

36819

(3013650) Neutrophils [#/volume] in Blood by Automated count

3307

27603

1.48

43.22

8.7

8.9

3.80

3.93

e9/l

3.24

2861

24224

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5056

46740

1.83

39.16

6.0

5.3

1.75

2.02

mu/l

2.97

4748

43527

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2778

22677

1.45

38.95

2.6

2.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

425

2198

2.01

37.42

1.6

356.03

314.17

mu/l

0.26

395

1940

(3019225) pH of Specimen

731

4518

1.71

36.31

4.4

3.9

—

(3018010) Neutrophils/100 leukocytes in Blood

2761

22828

1.41

34.26

5.7

5.8

56.05

56.67

2.18

2572

21367

(3015377) Calcium [Moles/volume] in Serum or Plasma

2052

16111

1.43

34.04

3.6

3.2

2.37

2.36

mmol/l

1.18

1765

14232

(3006504) Eosinophils/100 leukocytes in Blood

2704

22309

1.41

33.78

5.8

5.9

2.85

2.78

0.84

2510

20824

(3019069) Monocytes/100 leukocytes in Blood

2716

22431

1.41

33.70

6.0

6.2

8.02

8.17

1.89

2525

20983

(3019550) Sodium [Moles/volume] in Serum or Plasma

5166

48432

1.84

33.15

14.5

13.1

139.71

139.66

mmol/l

0.81

5069

47160

(3002030) Lymphocytes/100 leukocytes in Blood

2782

23147

1.40

32.64

5.9

6.0

29.65

29.06

2.34

2593

21700

(3022096) Basophils/100 leukocytes in Blood

2615

21546

1.40

32.41

5.8

6.0

0.70

0.69

0.33

2413

20021

(3037467) Urinalysis macro (dipstick) panel - Urine

3827

33669

1.43

32.34

4.8

4.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5156

48379

1.81

32.02

14.0

12.2

18.72

20.05

mg/l

2.27

4108

37653

(3031040) Bacteria [#/volume] in Urine by Automated count

3733

32732

1.42

31.87

5.0

4.4

3926.98

1747.00

e6/l

0.66

366

(3023103) Potassium [Moles/volume] in Serum or Plasma

5169

48577

1.81

31.37

14.7

13.2

3.92

mmol/l

0.08

5062

47191

(3013115) Eosinophils [#/volume] in Blood

2936

24751

1.39

31.31

5.9

6.0

0.18

e9/l

0.11

2572

21893

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2632

21798

1.39

31.18

2.5

2.3

79.48

77.68

nmol/l

2.61

2390

19845

(40768797) Stomach Pathology biopsy report

972

6684

1.55

30.91

1.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4523

41196

1.51

30.90

5.0

4.5

14.52

14.61

pmol/l

1.75

4207

38015

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

251

1150

2.24

30.26

4.0

3.6

26.50

35.11

u/ml

0.91

244

1115

(3006315) Basophils [#/volume] in Blood

2839

23906

1.38

29.90

5.6

5.8

0.04

e9/l

0.05

2445

20759

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1829

14321

1.41

29.77

2.5

2.4

56.48

57.95

u/l

0.68

1687

13143

(3001604) Monocytes [#/volume] in Blood

2828

23850

1.37

29.22

5.7

5.8

0.52

0.55

e9/l

7.40

2442

20751

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

267

1273

2.15

29.16

1.2

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2681

22425

1.37

29.12

5.8

6.2

—

(3048689) Calprotectin [Mass/mass] in Stool

975

6796

1.53

28.95

2.1

2.2

81.60

112.40

ug/g

3.77

752

5296

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2264

18442

1.38

28.89

2.0

1.9

104.59

99.28

pmol/l

4.77

1065

9061

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

181

740

2.49

28.27

1.9

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1445

10950

1.43

27.92

1.8

1.7

1.00

1.01

mg/l

0.01

1062

8236

(3019198) Lymphocytes [#/volume] in Blood

2894

24604

1.36

27.85

5.7

5.8

1.96

1.93

e9/l

0.31

2572

21937

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5349

51063

2.02

27.38

11.0

9.8

23.77

23.63

u/l

0.16

5229

49341

(3033658) Prothrombin time (PT) actual/Normal

1480

11302

1.42

27.28

3.6

3.5

97.80

96.05

1.98

1444

10961

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2437

20224

1.36

27.10

5.1

5.2

1.22

mmol/l

0.83

2222

18403

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2666

22442

1.36

27.01

6.0

5.8

1.22

mmol/l

0.71

2384

18892

(3007164) IgA [Mass/volume] in Serum or Plasma

1371

10511

1.40

24.20

1.4

2.13

2.21

g/l

0.70

771

6382

(3024561) Albumin [Mass/volume] in Serum or Plasma

2305

19197

1.34

24.06

4.0

4.4

36.78

36.01

g/l

10.92

2151

17812

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3623

32259

1.35

23.84

3.2

2.9

37.59

38.80

u/l

0.35

3386

30233

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1293

9851

1.41

23.57

1.4

1.3

30.41

29.21

iu/ml

0.12

402

3256

(3003327) Ova and parasites identified in Stool by Light microscopy

325

1841

1.81

21.56

1.9

1.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1625

13002

1.35

21.55

2.0

120.37

157.29

u/l

3.92

1527

12165

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

791

5607

1.48

21.07

4.4

4.2

33.30

33.37

0.07

542

3881

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1563

12562

1.34

19.77

1.4

1.3

1.46

1.55

u/ml

0.11

392

3472

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4885

46108

1.46

19.41

4.5

4.2

5.72

5.74

mmol/l

0.77

4554

42426

(40768443) Skin Pathology biopsy report

361

2174

1.71

19.35

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1655

13492

1.32

18.76

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1202

9385

1.36

18.17

1.3

10.50

11.26

u/ml

0.10

432

3792

(3036481) Cortisol [Moles/volume] in Serum or Plasma

664

4678

1.48

18.09

2.1

381.09

377.97

nmol/l

0.17

610

4282

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2712

23676

1.28

18.05

3.0

2.9

86.25

87.01

ug/l

0.06

2536

22120

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1407

11260

1.33

18.01

1.7

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2935

25881

1.28

18.01

4.0

6.36

6.47

mmol/l

2.33

2734

23756

(3013512) EKG study

1524

12375

1.32

17.53

3.7

3.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

125

539

2.35

17.50

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

540

3697

1.51

16.89

2.5

2.4

16.74

25.58

au/ml

2.07

312

(40758558) Short blood count panel - Blood

1492

12153

1.31

16.61

6.9

6.6

—

(3022145) Colonoscopy Study observation

722

5305

1.41

15.58

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

497

3409

1.50

15.37

1.3

60.07

45.09

au/ml

0.53

189

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

610

4373

1.44

15.06

2.2

2.3

31.73

37.24

u/l

1.83

536

3673

(3013139) Helicobacter pylori Ag [Presence] in Stool

524

3658

1.48

14.85

1.3

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1073

8473

1.33

14.64

2.5

2.8

2.44

2.45

mmol/l

1.16

936

7388

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1835

15551

1.27

14.57

3.2

31.68

71.40

ng/l

0.57

1007

9037

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

324

2.59

14.45

1.1

—

(36660697) Celiac disease serology panel - Serum

621

4499

1.43

14.45

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

5499

53783

2.12

14.38

21.3

18.2

39.66

39.56

0.38

5298

50713

(40761511) CBC panel - Blood by Automated count

5249

50689

1.55

14.36

12.7

11.5

—

(4200892) Spirometry reversibility

481

3324

1.49

14.33

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

963

7514

1.34

14.22

1.4

502.07

600.29

titre

1.00

232

1682

(3007853) Bacteria identified in Skin by Aerobe culture

694

5160

1.39

13.90

1.7

—

(3007461) Platelets [#/volume] in Blood

5501

53850

2.10

13.69

21.4

18.3

263.08

266.03

e9/l

3.09

5409

52608

(3035941) MCH [Entitic mass]

5503

53880

2.11

13.63

21.2

18.2

30.17

30.09

3.06

5457

53217

(3042936) Bacteria identified in Isolate by Culture

770

5841

1.37

13.63

1.9

—

(3024731) MCV [Entitic volume]

5503

53882

2.11

13.60

21.3

18.2

90.88

90.69

2.54

5457

53220

(3010813) Leukocytes [#/volume] in Blood

5503

53884

2.10

13.56

21.4

18.3

6.50

6.59

e9/l

2.65

5402

52506

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1285

10499

1.29

13.52

2.5

2.8

955.79

1016.81

ng/l

0.18

1059

8843

(3026361) Erythrocytes [#/volume] in Blood

5503

53888

2.10

13.50

21.3

18.3

4.42

e12/l

0.02

5402

52538

(3000963) Hemoglobin [Mass/volume] in Blood

5504

53903

2.11

13.47

21.5

18.4

132.62

132.27

g/l

1.66

5462

53243

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3748

34586

1.25

13.46

3.7

3.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4506

42555

1.30

13.12

5.3

5.1

38.21

38.63

mmol/mol

2.97

4220

39559

(3018095) Leukocytes [#/volume] in Urine

1859

15957

1.25

12.80

3.5

3.4

65.42

95.07

e6/l

2.39

1235

10590

(3000494) Fungus identified in Specimen by Culture

715

5422

1.37

12.63

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4729

45028

1.32

12.43

3.9

3.6

1.22

1.23

mmol/l

0.43

4409

41504

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

978

7799

1.31

12.22

3.5

3.4

133.79

287.94

ng/l

2.22

617

5290

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4918

47127

1.35

12.12

4.3

4.1

4.86

4.87

mmol/l

0.51

4634

43981

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4889

46830

1.34

11.89

4.3

4.0

1.59

1.58

mmol/l

0.66

4595

43525

(3011397) Hemoglobin [Presence] in Urine by Test strip

1366

11409

1.26

11.76

3.6

3.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4978

47850

1.36

11.52

4.8

4.5

2.86

2.88

mmol/l

0.53

4677

44433

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

540

3979

1.40

11.34

2.1

2.2

0.23

0.22

g/l

5.21

507

3746

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

839

6622

1.31

11.23

2.4

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1214

10047

1.27

11.22

1.5

22.31

21.52

nmol/l

1.08

1026

8596

(43055514) Macroprolactin [Presence] in Serum or Plasma

156

3.03

11.16

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

1514

12902

1.24

10.73

2.9

64.42

61.48

e6/l

0.04

1136

9614

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

830

6585

1.31

10.66

2.5

2.6

5.96

4.48

e6/l

0.54

429

3330

(3015736) pH of Urine

2195

19468

1.21

10.40

3.5

3.4

5.98

5.94

0.30

214

1642

(3023323) Follitropin [Units/volume] in Serum or Plasma

502

3710

1.39

10.34

1.4

1.3

26.87

29.91

iu/l

1.21

439

3227

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

920

7429

1.29

10.30

2.5

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

637

4893

1.34

10.26

2.0

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

267

1750

1.55

10.23

2.1

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

232

1477

1.60

10.09

1.2

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

893

7204

1.28

10.06

2.4

2.5

1.47

1.79

e6/l

0.31

486

3924

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

248

1609

1.57

9.95

1.9

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

305

2073

1.50

9.88

1.5

1.7

3.17

3.95

mg/l

1.00

211

1508

(3009214) Lutropin [Units/volume] in Serum or Plasma

210

1315

1.62

9.78

1.3

12.87

13.79

u/l

0.39

176

1076

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

510

3817

1.37

9.72

1.9

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

258

1700

1.54

9.67

1.3

42.33

45.88

u/ml

0.07

121

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

339

2371

1.46

9.52

2.4

—

(3052851) Hemolysis interference index of Serum or Plasma

210

1327

1.61

9.44

2.4

2.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

307

2110

1.48

9.42

2.0

1.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

665

5204

1.32

9.39

2.4

2.5

5.59

6.82

umol/l

1.48

553

4387

(42529406) Shigella sp [Presence] in Stool by Culture

231

1498

1.57

9.31

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

230

1492

1.56

9.26

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

582

4482

1.33

9.19

3.6

3.8

11.59

27.68

ug/l

0.94

429

3472

(3005322) IgE [Units/volume] in Serum or Plasma

466

3478

1.37

9.04

1.3

165.70

166.92

u/ml

0.01

435

3214

(36304419) Bacteria [Presence] in Urine

1380

11833

1.22

8.94

2.7

2.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.12

8.70

1.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1765

15532

1.20

8.67

3.1

28.77

31.46

u/l

1.64

1683

14738

(3017732) Neutrophils [#/volume] in Blood

469

3532

1.36

8.59

2.7

2.6

3.77

4.41

e9/l

3.04

355

2931

(3000570) Elastase.pancreatic [Mass/mass] in Stool

216

1407

1.56

8.56

1.4

297.36

288.12

ug/g

0.29

124

751

(40758358) Immune stain study

8.20

8.56

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

113

619

1.84

8.55

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.05

8.51

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

172

1066

1.63

8.41

1.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

310

4317

0.70

8.32

4.0

3.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

112

618

1.83

8.30

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1341

11539

1.21

8.29

2.2

2.74

2.88

mg/l

1.54

1136

9875

(3025468) Yersinia sp identified in Specimen by Organism specific culture

111

611

1.83

8.29

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

111

612

1.83

8.25

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

111

614

1.82

8.16

1.4

—

(3044889) 12 lead EKG panel

3404

31783

1.18

8.15

3.4

3.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

631

1.81

8.07

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1288

11076

1.21

7.97

2.2

2.3

3356.09

3661.72

umol/l

0.11

1122

9716

(3009261) Glucose [Presence] in Urine by Test strip

2670

24471

1.17

7.93

3.8

3.7

0.00

estimate

1.80

397

4586

(3023511) Choriogonadotropin [Units/volume] in Urine

238

1611

1.50

7.92

1.5

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

931

7759

1.24

7.81

1.7

1124.97

1192.52

nmol/l

1.23

714

5872

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

296

2101

1.43

7.73

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

386

2869

1.37

7.70

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

323

2342

1.40

7.49

1.3

0.87

1.36

u/ml

0.31

210

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

226

1536

1.49

7.40

1.3

6.51

4.41

u/ml

0.21

160

(3034274) Bile acid [Moles/volume] in Serum --fasting

153

953

1.62

7.38

2.0

2.2

5.63

6.24

umol/l

0.20

113

692

(3021601) Nitrite [Presence] in Urine by Test strip

2640

24269

1.17

7.31

5.2

4.9

0.00

estimate

0.33

399

4583

(3030467) Casts [#/volume] in Urine by Automated count

1370

11933

1.20

7.30

2.8

2.9

0.29

0.37

e6/l

1.13

1004

8862

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

669

5409

1.27

7.30

5.7

6.0

—

(3025130) Human papilloma virus identified in Specimen

174

1123

1.57

7.24

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

123

729

1.70

7.19

1.2

0.28

0.30

nmol/l

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

200

1334

1.52

7.18

1.2

1.3

43.07

43.12

u/ml

0.00

152

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

179

1170

1.55

7.05

1.5

1.4

27.38

28.91

u/l

0.24

150

968

(3035350) Ketones [Presence] in Urine by Test strip

2623

24152

1.16

6.99

3.8

3.7

0.00

estimate

0.31

414

4837

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

526

4158

1.29

6.87

2.8

3.4

35.36

53.19

u/ml

2.58

513

4011

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

402

3062

1.34

6.86

1.0

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

225

1553

1.47

6.85

1.3

3.32

8.55

u/ml

2.48

269

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

308

2254

1.39

6.78

1.1

1.98

3.09

u/ml

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

134

827

1.64

6.74

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

134

827

1.64

6.74

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

222

1535

1.46

6.70

1.4

—

(3022621) pH of Urine by Test strip

419

3224

1.32

6.67

3.3

3.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

463

3613

1.31

6.66

3.5

3.2

74.58

79.90

ng/l

0.92

405

3084

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

357

1.97

6.66

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

161

1046

1.56

6.55

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

252

1795

1.42

6.50

1.6

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

111

659

1.70

6.49

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

127

782

1.64

6.47

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

361

1.95

6.46

1.3

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

497

3932

1.29

6.45

3.6

3.3

4.44

4.49

pmol/l

0.55

436

3501

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

129

799

1.63

6.42

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

225

1576

1.45

6.37

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

350

1.95

6.32

2.0

2.1

20.28

18.95

nmol/l

0.50

330

(1002224) Polysomnography panel

265

1915

1.40

6.31

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

721

5979

1.24

6.27

1.8

2.0

29.36

29.30

0.10

711

5779

(3023368) Bacteria identified in Blood by Culture

1162

10100

1.19

6.22

3.8

3.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

373

2864

1.32

6.05

2.1

2.2

3.77

5.78

ug/l

4.48

309

2435

(3018418) pH of Serum or Plasma

1528

13617

1.17

6.02

3.7

7.40

0.22

214

2644

(3022217) INR in Platelet poor plasma by Coagulation assay

2032

18519

1.15

5.91

11.4

11.2

1.16

1.15

inr

0.33

509

5573

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

573

4681

1.25

5.71

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

803

6801

1.21

5.67

2.7

3.1

0.82

mmol/l

0.57

741

6359

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

350

1.90

5.66

1.1

—

(3019150) Specific gravity of Urine by Refractometry

1177

10316

1.18

5.66

4.2

4.1

1.02

kg/l

0.28

215

1587

(3000492) Spirometry study

560

4572

1.25

5.61

1.4

—

(3003338) MCHC [Mass/volume]

4333

41719

1.17

5.58

18.4

15.6

331.40

331.00

g/l

2.61

4314

41428

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

163

1111

1.48

5.37

1.6

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

110

688

1.61

5.33

1.4

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

141

934

1.52

5.33

1.1

1.39

0.99

u/ml

0.26

374

(3026008) Bacteria identified in Urine by Culture

1763

15997

1.15

5.32

3.1

2.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

201

1429

1.42

5.31

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

147

985

1.51

5.27

1.1

4.70

4.81

u/ml

0.03

492

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

131

859

1.54

5.20

1.1

10.33

12.64

au/ml

—

(3049717) Cytology report of Urine Cyto stain

142

948

1.51

5.18

2.1

2.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

1094

1.47

5.02

1.2

1.1

2.29

2.18

u/ml

0.04

527

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

268

1.95

4.90

1.8

2.2

99.09

100.89

0.15

240

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

296

3819

0.76

4.88

2.8

3.3

1.23

1.24

mmol/l

0.87

271

3306

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

352

2772

1.29

4.79

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

404

3240

1.27

4.75

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

750

6422

1.19

4.69

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

134

906

1.49

4.65

1.1

1.32

1.41

u/ml

0.05

428

(3030981) Hyaline casts [#/volume] in Urine by Automated count

256

1943

1.33

4.57

2.4

0.17

0.28

e6/l

1.57

245

1866

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

341

1.80

4.52

1.5

4.81

6.57

u/l

0.73

281

(46235355) HIV 1 and 2 tests - Meaningful Use set

1203

10733

1.15

4.50

2.0

1.9

—

(3025941) Bacteria identified in Stool by Culture

373

2988

1.27

4.44

1.3

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

341

2704

1.28

4.42

1.1

90.00

196.32

titre

—

(3005719) IgG [Mass/volume] in Serum or Plasma

433

3534

1.24

4.39

2.6

2.7

10.29

10.36

g/l

0.14

402

3245

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

613

5198

1.20

4.27

1.7

1.6

1.38

1.34

0.62

543

4607

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

683

5855

1.19

4.22

1.5

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

703

6043

1.19

4.21

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

382

3100

1.25

4.09

2.3

2.1

5357.87

5441.64

u/l

0.02

130

1244

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

181

2.05

4.08

1.1

1.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

190

1404

1.37

4.08

3.6

3.5

25.00

24.95

mmol/l

0.11

174

1292

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

552

1.59

4.07

2.2

2.0

12.58

27.16

mg/l

2.86

147

(3022313) Gas panel - Capillary blood

209

1571

1.34

4.03

3.5

3.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

260

2017

1.30

4.02

2.3

2.0

41.68

39.78

u/l

1.00

239

1819

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

143

2.17

3.98

1.6

0.32

0.42

ug/l

0.80

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

427

1.65

3.86

1.3

1.2

44.17

46.48

u/ml

—

(3000850) Epithelial cells [#/volume] in Urine

1016

9049

1.15

3.86

2.4

6.89

8.03

e6/l

1.92

906

8027

(3035637) Corticotropin [Mass/volume] in Plasma

608

1.54

3.84

1.2

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

422

1.64

3.77

3.4

3.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

381

3126

1.23

3.72

1.6

—

(3026782) Osmolality of Urine

949

8436

1.15

3.70

2.6

2.7

504.27

505.26

mosm/kgh2o

0.05

804

7173

(3008898) HLA-B27 [Presence]

265

2090

1.28

3.64

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

279

2215

1.27

3.63

3.2

3.3

5.05

5.17

kpa

1.92

261

2110

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

357

4334

0.81

3.57

2.8

3.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

360

2950

1.24

3.57

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

771

6771

1.16

3.54

2.3

13.79

13.28

umol/l

1.23

726

6285

(3011288) Drugs identified in Urine by Screen method

177

1327

1.34

3.52

3.9

2.7

—

(3009343) pH of Capillary blood

275

2189

1.27

3.52

3.3

7.43

7.42

1.38

302

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

179

1346

1.34

3.49

1.9

2.4

158.62

181.82

3.80

167

1277

(3024891) Influenza virus A+B Ag [Presence] in Specimen

169

1262

1.35

3.45

1.2

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

1025

0.63

3.45

3.2

3.5

57.31

57.19

0.03

1025

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

539

4612

1.19

3.42

1.3

1.2

146.01

155.51

iu/ml

0.23

223

1836

(3003458) Phosphate [Moles/volume] in Serum or Plasma

591

5100

1.18

3.40

4.8

4.9

1.04

mmol/l

0.05

539

4710

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

411

1.61

3.40

1.3

1.2

2.25

5.88

u/ml

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

555

1.52

3.36

1.2

55.18

60.54

u/l

0.71

507

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

168

1.97

3.33

2.5

2.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

262

1.76

3.30

1.3

1.8

114.20

129.29

1.05

245

(3051611) Lipemic interference index of Serum or Plasma

454

1.57

3.29

2.5

2.9

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

216

1684

1.29

3.28

4.0

24.68

24.26

mmol/l

1.19

210

1652

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

593

1.49

3.22

1.4

1.3

667.99

335.86

pmol/l

0.61

521

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

202

1568

1.30

3.18

1.9

4.00

9.38

iu/l

0.53

606

(3002032) Base excess in Venous blood by calculation

377

3146

1.21

3.16

3.9

3.6

2.23

1.96

mmol/l

0.71

337

2707

(3026389) Candida sp identified in Specimen by Organism specific culture

122

879

1.40

3.14

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.43

3.10

2.1

1.9

—

(3028271) Lactate [Moles/volume] in Capillary blood

626

0.56

3.08

1.7

1.57

1.65

mmol/l

0.20

613

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.00

3.08

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.26

3.02

1.2

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

808

0.62

3.00

2.1

2.3

17.11

16.29

1.03

397

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1024

9277

1.13

2.97

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

212

1674

1.28

2.95

1.7

1.8

1.18

g/l

0.01

205

1582

(3000764) Benzodiazepines [Presence] in Urine

242

1943

1.26

2.93

2.7

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

164

1253

1.32

2.93

1.3

2.06

3.16

u/ml

0.35

(1001926) Buprenorphine [Presence] in Urine by Screen method

190

1486

1.29

2.86

2.8

2.0

—

(40761535) Cells panel - Urine sediment

417

3550

1.19

2.85

3.4

3.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

158

1209

1.32

2.80

1.3

410.44

486.87

mg/l

2.49

151

1150

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

217

1731

1.26

2.80

2.2

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

644

5683

1.15

2.79

2.3

2.4

22.86

22.19

0.68

565

4817

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

216

1.76

2.79

1.8

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

338

1.60

2.78

1.5

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

217

1.76

2.75

1.8

1.6

—

(3010838) Calcium [Moles/time] in 24 hour Urine

133

996

1.34

2.74

2.0

1.9

5.13

5.12

mmol/24h

0.02

117

883

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.00

2.72

1.0

—

(3027008) Opiates [Presence] in Urine

241

1953

1.24

2.72

2.7

1.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

219

1.74

2.67

1.3

133.19

132.17

mmol/24h

0.04

219

(3028300) Cannabinoids [Presence] in Urine

241

1958

1.24

2.66

2.7

1.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

258

2112

1.23

2.66

3.3

1.61

1.79

mmol/l

0.33

195

1582

(3017446) Testosterone [Moles/volume] in Serum or Plasma

528

1.46

2.65

1.2

1.3

1.02

1.38

nmol/l

2.82

442

(3003694) ABO and Rh group [Type] in Blood

1519

14141

1.10

2.64

1.5

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.15

2.64

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

167

1302

1.29

2.61

2.1

2.5

3.32

3.61

g/l

2.00

154

1227

(3012544) pH of Venous blood

383

3267

1.18

2.58

3.9

3.5

7.43

7.38

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.00

2.56

0.0

1.5

—

3.83

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

284

1.62

2.53

1.0

1.1

11.34

7.42

u/ml

—

(3037121) Protein [Mass/volume] in Urine

182

1444

1.27

2.49

2.8

3.0

0.27

0.31

g/l

0.20

514

(3028707) Methadone [Presence] in Urine by Screen method

115

857

1.35

2.48

3.7

2.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.32

2.48

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

251

2068

1.22

2.46

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

691

6184

1.13

2.45

2.2

2.3

2.43

2.42

g/l

0.11

637

5673

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

334

1.56

2.45

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

334

1.56

2.45

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

334

1.56

2.45

1.6

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

350

1.55

2.45

1.5

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.46

2.44

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

252

2079

1.22

2.44

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

411

3545

1.17

2.44

1.8

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

252

2081

1.22

2.42

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

202

1629

1.25

2.42

1.7

1.9

0.23

g/l

0.15

195

1535

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

251

2074

1.22

2.40

1.4

—

(3027944) Amphetamines [Presence] in Urine

235

1929

1.23

2.39

2.5

1.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

111

828

1.35

2.39

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

281

1.61

2.39

1.5

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

306

2586

1.19

2.32

3.1

3.0

4.63

4.58

kpa

0.15

297

2501

(3038177) Helicobacter pylori Ab [Presence] in Serum

123

937

1.32

2.31

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

331

1.55

2.31

3.0

2.2

556.78

506.54

e6/l

0.28

270

(3021447) Carbon dioxide [Partial pressure] in Venous blood

368

3161

1.18

2.31

4.0

3.5

5.89

5.82

kpa

0.64

359

3071

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

133

1.88

2.30

3.3

2.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

112

1.97

2.30

1.1

1.3

36.38

39.06

g/l

0.41

(3028026) IgM [Mass/volume] in Serum or Plasma

324

2757

1.19

2.28

1.6

1.8

1.23

1.35

g/l

0.86

297

2530

(3002385) Erythrocyte distribution width [Ratio]

4347

42528

1.10

2.28

16.4

14.6

15.08

14.75

2.85

4310

41785

(3022806) Fractional oxyhemoglobin in Capillary blood

509

0.59

2.27

1.5

1.7

91.22

90.21

0.56

501

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.56

2.27

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

455

1.46

2.26

1.1

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

481

4226

1.15

2.26

4.0

4.1

236.95

241.44

u/l

0.30

438

3976

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

149

1171

1.28

2.24

1.4

0.34

0.45

nmol/l

1.46

117

907

(3012501) Base excess in Blood by calculation

888

0.69

2.18

3.2

2.74

2.57

mmol/l

0.15

592

(3006462) Nitrate [Presence] in Urine

265

1.59

2.17

3.3

3.5

—

(3032057) Clostridioides difficile [Presence] in Stool

2.02

2.15

2.0

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

166

1.75

2.14

1.4

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

655

1.36

2.13

1.0

0.30

0.35

u/ml

0.05

164

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

322

1.53

2.13

3.1

2.3

0.25

0.21

e9/l

0.85

269

(3010421) pH of Blood

1045

0.72

2.11

2.9

3.2

7.42

0.02

967

(3016879) Cocaine [Presence] in Urine

215

1775

1.22

2.11

2.8

2.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1953

18545

1.08

2.09

3.9

3.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

364

3156

1.16

2.06

5.7

6.0

1.20

1.26

mmol/l

0.79

357

3081

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

265

2238

1.19

2.06

1.4

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

176

1427

1.24

2.06

2.2

2.83

2.96

g/l

1.05

150

1280

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.50

2.05

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1336

12503

1.09

2.03

1.6

1.36

1.34

mmol/l

0.40

1193

10589

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.40

2.02

2.3

2.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

125

1.84

2.02

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

749

1.33

2.00

1.0

1.1

4.18

4.06

u/ml

0.02

289

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.82

2.00

1.0

0.19

0.35

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

286

0.49

1.99

1.2

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

836

0.70

1.98

2.5

2.6

13.27

13.19

0.26

824

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

186

1.67

1.97

1.1

102.31

94.30

0.51

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

141

1.78

1.96

1.2

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

171

1391

1.24

1.96

2.2

9.47

9.97

g/l

0.95

144

1232

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

362

1.47

1.94

1.6

1.3

4.70

5.16

umol/l

0.40

336

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.45

1.92

2.2

1.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

195

1.64

1.92

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

195

1.64

1.92

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

421

1.43

1.92

1.1

—

(3036489) Thrombin time

208

1731

1.21

1.91

1.7

2.0

21.43

21.12

0.29

178

1453

(3000991) Gas panel - Venous blood

339

2943

1.16

1.91

7.3

7.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

150

1.74

1.90

1.1

5.5

7750.26

59.98

mg/l

0.48

105

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.92

1.90

1.1

1.61

0.61

umol/24h

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

268

2286

1.18

1.88

1.7

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

160

1299

1.24

1.88

2.7

2.1

10.70

11.20

mg/l

0.36

143

1204

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

1.82

1.88

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1499

1.22

1.87

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1500

1.22

1.86

2.2

7.06

7.51

g/l

3.06

156

1352

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.39

1.85

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

350

1.46

1.84

1.2

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

133

1060

1.26

1.84

1.2

3.60

3.68

mmol/l

0.56

122

992

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

107

831

1.29

1.82

1.1

1.61

3.67

u/ml

2.57

401

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

418

1.42

1.81

1.1

205.06

219.24

mg/l

0.48

366

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

183

1.64

1.81

1.1

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

349

3052

1.15

1.80

2.5

2.8

189.91

151.06

ng/l

0.84

312

2767

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

199

1.61

1.79

1.4

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

1498

1.22

1.78

2.2

3.56

3.59

g/l

0.05

155

1352

(3014133) Dog dander IgE Ab [Units/volume] in Serum

104

808

1.29

1.77

1.1

1.44

3.49

u/ml

2.41

360

(3027231) Wheat IgE Ab [Units/volume] in Serum

102

1.87

1.75

1.0

0.67

1.05

u/ml

0.24

(3009677) Dengue virus Ab [Presence] in Serum

3.34

1.74

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

193

1.61

1.74

1.1

1.0

100.38

91.11

0.93

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

628

1.33

1.72

4.1

4.5

169.49

92.71

u/ml

0.24

192

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

431

1.40

1.72

1.3

1.1

32.81

35.03

mg/l

0.28

362

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

248

2121

1.18

1.72

1.3

212.95

240.44

miu/ml

0.66

117

1067

(3017354) Segmented neutrophils/100 leukocytes in Blood

381

1.42

1.71

3.6

2.9

57.96

55.96

0.30

337

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

716

1.30

1.71

1.2

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

126

1009

1.25

1.70

1.2

1.4

—

(3024928) Oxygen saturation in Venous blood

719

1.30

1.66

2.6

3.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

649

1.31

1.66

1.6

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

649

1.31

1.66

1.6

1.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

457

4094

1.13

1.66

2.7

2.5

1.69

1.81

2.02

398

3597

(3036071) Salmonella sp Ab [Titer] in Serum

157

1.66

1.65

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

444

1.38

1.63

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

444

1.38

1.63

1.1

1.2

—

(3005033) Fetal Nuchal fold Thickness US

198

1670

1.19

1.63

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

120

1.75

1.62

1.3

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

191

1607

1.20

1.61

1.1

1.54

6.67

u/ml

2.93

210

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

445

1.37

1.61

1.1

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

173

1444

1.20

1.60

1.5

1.7

445.00

327.14

titre

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.33

1.58

1.3

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

131

1064

1.24

1.58

1.3

6.64

34.16

e6/l

1.53

102

795

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

131

1065

1.24

1.57

1.4

170.42

5242.57

e6/l

0.81

104

847

(3045414) Leukocytes [Presence] in Urine

265

2298

1.16

1.57

1.8

1.9

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

198

1677

1.19

1.56

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

711

6552

1.10

1.54

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

545

1.33

1.52

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

290

1.45

1.52

1.2

1.4

38598.64

69275.99

e6/l

0.39

162

(40768446) Kidney Pathology biopsy report

142

0.42

1.51

1.7

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

434

1.36

1.50

1.3

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.86

1.50

1.7

3.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

144

1189

1.22

1.50

2.3

2.1

39.23

38.13

g/l

1.46

117

1038

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

375

1.39

1.49

1.1

6.34

9.91

iu/ml

0.83

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

1.78

1.48

1.0

1.2

194.31

94.80

nmol/l

1.23

(40758292) HTLV I+II Ab panel - Serum

2.00

1.48

1.3

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

202

1.54

1.48

1.5

2.3

120.51

281.35

ug/l

0.40

192

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

317

1.42

1.47

1.3

1.2

80.36

79.75

u/l

0.01

287

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

141

1165

1.22

1.47

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

360

1.39

1.46

1.1

1.0

0.41

1.99

u/ml

0.82

106

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

171

1.58

1.45

2.1

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

171

1.58

1.45

2.1

1.7

—

(3020630) Protein [Mass/volume] in Serum or Plasma

359

3200

1.13

1.45

2.3

2.5

66.95

66.68

g/l

0.31

310

2903

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

403

1.37

1.45

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

369

1.39

1.44

4.2

2.9

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.13

1.44

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

311

1.42

1.3

1.2

25.61

22.38

u/l

0.08

271

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

311

1.42

3.5

4.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

439

1.35

1.42

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

262

1.45

1.40

2.9

3.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

304

1.42

1.40

1.1

0.11

12.69

nmol/l

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

173

1.56

1.39

2.1

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

441

1.34

1.38

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

441

1.34

1.38

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

441

1.34

1.38

1.1

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

186

1588

1.18

1.37

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

104

1.73

1.36

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

432

3911

1.11

1.35

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

201

1730

1.17

1.35

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

160

1351

1.19

1.35

2.7

2.5

—

(1616796) Gas panel - Central venous blood

854

0.77

1.32

2.4

3.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

258

1.44

1.31

1.5

1.3

28.57

68.18

titre

—

(3035320) C reactive protein [Mass/volume] in Body fluid

360

1.36

1.29

2.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

343

1.37

1.29

1.0

309.11

298.48

mg/l

0.40

303

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

169

1.54

1.28

1.0

8.75

13.52

u/ml

0.47

109

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

106

865

1.23

1.28

2.0

1.8

—

(3020491) Glucose [Moles/volume] in Blood

353

1.36

1.27

1.6

6.58

6.22

mmol/l

0.34

253

(3011985) Renin [Units/volume] in Plasma

642

1.27

1.26

1.5

1.4

57.49

57.72

mu/l

0.00

576

(3051387) C reactive protein [Mass/volume] in Capillary blood

114

940

1.22

1.25

3.5

17.33

24.14

mg/l

1.77

575

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

116

959

1.21

1.24

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

261

1.42

1.24

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.40

1.24

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

203

0.54

1.24

1.3

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

547

1.28

1.23

1.0

1.1

1.49

1.50

g/l

0.10

489

(3012494) Peanut IgE Ab [Units/volume] in Serum

171

1.52

1.23

1.1

1.0

0.21

2.83

u/ml

1.40

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

409

0.68

1.22

1.2

1.6

—

(3011412) CD3 cells [#/volume] in Blood

460

1.31

1.21

2.8

2.1

1.45

1.24

e9/l

0.88

404

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

116

1.64

1.21

1.1

89.40

82.90

—

(3000060) B lymphocytes [#/volume] in Blood

148

1.56

1.19

2.8

1.9

140.00

153.95

e6/l

0.11

(3036180) Methadone [Presence] in Urine

205

1.47

1.19

3.4

3.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

392

1.33

1.19

1.7

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

515

1.28

1.18

1.4

6.30

6.64

g/l

0.53

355

(3024139) IgG subclass 3 [Mass/volume] in Serum

515

1.28

1.18

1.4

0.39

g/l

0.02

354

(3028192) IgG subclass 2 [Mass/volume] in Serum

515

1.28

1.18

1.4

3.30

2.84

g/l

1.00

355

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

117

1.63

1.17

1.1

77.20

69.43

—

(3023410) Appearance of Cerebral spinal fluid

498

1.29

1.17

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

199

0.55

1.17

1.3

1.5

—

(3023419) Bacteria identified in Sputum by Culture

535

1.27

1.15

2.1

2.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

1.14

0.0

1.3

—

12.41

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

122

1447

0.84

1.14

1.4

1.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

318

3522

0.90

1.12

3.8

3.9

0.73

0.67

0.16

109

1024

(4062490) Immunoglobulin typing, IgG

511

1.28

1.11

1.4

—

(3045424) Erythrocytes [Presence] in Urine

100

826

1.21

1.11

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

397

1.31

1.11

5.5

6.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

372

1.32

1.09

1.2

1.4

1.83

2.04

mmol/l

1.47

347

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

269

1.38

1.08

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

156

1346

1.16

1.07

1.2

88.89

160.18

titre

—

111

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

0.60

1.07

1.2

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

108

904

1.20

1.06

1.2

255.37

272.83

u/ml

0.33

572

(3020911) Cortisol [Moles/time] in 24 hour Urine

211

1.42

1.05

1.4

1.3

51.02

156.12

nmol/24h

0.82

211

(3020891) Body temperature

121

1424

0.85

1.05

4.0

4.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.71

1.05

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

340

1.33

1.04

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1383

13260

1.06

1.04

3.3

3.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

578

0.76

1.04

1.8

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

141

1212

1.17

1.03

2.1

2.2

188.17

496.65

ug/l

1.11

122

1107

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

138

1.52

1.02

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

590

1.24

1.01

2.7

2.6

—

(4146454) Self-monitoring of blood glucose

404

1.29

1.00

2.8

2.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

1.46

0.99

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

1.46

0.99

1.4

1.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

123

1.55

0.99

1.1

102.53

110.09

0.76

116

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

259

2328

1.12

0.99

1.4

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.84

0.98

1.0

1.1

1.60

1.49

umol/24h

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.17

0.98

1.6

1.9

—

(3025159) Blasts/100 leukocytes in Blood

318

3490

0.91

0.97

3.8

4.2

0.01

0.33

1.36

850

(3045683) HLA typing for celiac disease panel - Blood or Tissue

362

1.30

0.97

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.95

0.97

1.4

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.95

0.97

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

148

1285

1.16

0.96

2.3

2.2

0.39

0.56

g/l

0.53

121

1111

(3009508) Creatinine [Moles/volume] in Urine

1331

12777

1.05

0.96

3.2

3.1

6.72

6.74

mmol/l

0.09

1153

10824

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

267

1.35

0.95

1.2

1.6

2.38

3.80

nmol/l

0.64

210

(3051593) INR in Capillary blood by Coagulation assay

157

1.47

0.95

5.1

11.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

259

1.35

0.94

2.1

2.7

—

(3008295) Osmolality of Serum or Plasma

479

1.26

0.94

1.5

280.61

276.33

mosm/kgh2o

1.07

369

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.77

0.94

1.8

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

287

2605

1.11

0.93

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

734

1.20

0.93

1.5

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

789

1.19

0.92

1.3

1.5

0.50

0.63

g/l

1.38

589

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

123

1057

1.17

0.92

2.4

2.2

0.00

g/l

0.50

109

968

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1013

9669

1.06

0.90

1.6

53864108.83

27626812.12

pmol/l

0.65

880

8072

(21491868) Cryoglobulin [Mass/volume] in Serum

182

0.60

0.89

1.2

—

0.34

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

132

1145

1.16

0.89

2.4

2.2

0.01

g/l

0.03

118

1050

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

121

1043

1.16

0.88

2.5

2.2

0.00

g/l

-0.00

109

964

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

538

1.23

0.88

2.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

323

2959

1.10

0.88

5.9

6.8

7.80

8.55

mmol/l

1.49

309

2844

(3030313) Adrenal Ab [Titer] in Serum

1.79

0.87

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.86

0.87

1.0

0.15

0.61

u/ml

—

(3035933) Granulocytes/100 leukocytes in Blood

161

1.43

0.86

1.3

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

387

1.27

0.86

1.8

2.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

127

1103

1.15

0.85

1.3

5.73

3.91

ug/l

0.23

109

977

(3000475) Leukocytes [#/volume] in Synovial fluid

118

1020

1.16

0.84

1.8

1.7

6709.13

9514.89

e6/l

0.71

740

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.59

0.84

1.7

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

336

1.28

0.83

1.2

1.4

1779.47

2107.23

e6/l

0.34

244

(3026470) Cobalt [Mass/volume] in Blood

214

1.36

0.82

2.0

2.92

3.94

ug/l

0.51

199

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

810

1.18

0.81

1.2

4.12

3.09

u/ml

0.19

252

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

421

0.76

0.81

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

627

1.20

0.80

3.6

3.1

1.79

1.42

0.27

570

(40760888) Immunoglobulin light chains.free panel - Serum

860

0.84

0.79

3.4

3.2

—

(3011436) Histone Ab [Units/volume] in Serum

114

1.49

0.79

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

198

2197

0.90

0.79

6.0

6.9

25.00

24.70

mmol/l

0.70

193

2079

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

156

1.41

0.78

3.7

2.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

348

1.27

0.78

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

538

1.21

0.77

1.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

787

1.17

0.77

1.3

1.2

2.26

4.04

u/ml

2.78

309

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.76

0.0

4.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

110

956

1.15

0.75

1.9

2.3

—

(3048879) Bone marrow aspiration report

1.54

0.75

3.4

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

158

1.39

0.74

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

280

1.29

0.74

1.7

1.4

66.39

70.99

umol/l

1.09

280

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1024

0.86

0.73

3.9

3.1

1.49

1.43

mg/l

0.30

950

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.64

0.73

1.0

—

(3012441) Differential panel - Pleural fluid

272

1.29

0.72

1.2

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

126

1111

1.14

0.72

2.4

2.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.71

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.58

0.71

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

1.47

0.70

1.1

—

(3000012) Reticulocyte production index

477

0.80

0.70

1.3

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

221

1.31

0.69

1.7

1.8

1.23

1.37

nmol/l

0.28

176

(3037692) Legionella sp identified in Specimen by Organism specific culture

145

0.62

0.69

1.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.53

0.68

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.53

0.68

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.53

0.68

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

722

1.17

0.68

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

248

1.29

0.68

1.3

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

178

1.35

0.68

1.8

2.2

51.57

51.11

umol/l

0.02

156

(3022475) Manganese [Moles/volume] in Blood

1.67

0.68

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

231

1.30

0.67

1.3

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

170

1.35

0.67

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

287

2657

1.08

0.67

2.4

2.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.63

0.66

1.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

306

0.75

0.66

1.4

2.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

595

1.18

0.66

1.2

1.1

—

1.73

—

(3029937) Albumin [Presence] in Urine by Test strip

1320

12791

1.04

0.65

4.2

4.1

0.00

estimate

1.90

405

4561

(3021589) Normoblasts [#/volume] in Blood

2170

21229

1.04

0.65

7.9

8.7

0.00

e9/l

0.18

1708

17324

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

277

1.27

0.65

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

270

0.74

0.64

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

380

3564

1.07

0.64

2.5

2.4

72.63

69.16

ml/min/173m2

1.02

146

1387

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

296

1.25

0.63

1.5

4.80

5.26

u/l

0.45

250

(3017181) Myelocytes/100 leukocytes in Blood

357

3808

0.93

0.62

3.8

4.1

0.88

0.90

0.04

122

1159

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

104

1.44

0.62

1.1

1.2

16.27

15.91

pmol/l

0.04

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

456

4309

1.06

0.62

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

208

1.30

0.61

2.4

3.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.59

0.61

1.0

1.9

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

325

1.23

0.60

1.1

1.0

0.70

0.27

u/ml

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

453

1.19

0.60

1.4

27.80

31.17

nmol/l

0.46

406

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.57

0.60

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.60

0.0

1.4

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.60

0.0

1.3

—

14.22

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.60

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

122

1.39

0.60

1.2

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

174

1.32

0.59

1.1

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

546

1.17

0.59

5.9

5.1

380.37

372.27

umol/l

0.16

469

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

817

1.14

0.59

1.4

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.59

0.0

1.0

—

(3045788) Cell count panel - Pleural fluid

272

1.25

0.59

1.2

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.53

0.59

2.5

1.8

—

(3028433) Virus identified in Specimen by Culture

157

1.34

0.59

1.0

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

336

1.22

0.58

1.5

1.6

—

(3037756) Immunofixation for Serum or Plasma

734

1.15

0.58

1.9

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

172

1883

0.91

0.58

1.4

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

318

1.23

0.58

1.1

0.93

1.07

u/l

2.81

137

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

123

1.38

0.57

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

1.48

0.57

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.48

0.57

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

211

1.28

0.57

2.0

2.1

2.91

3.17

ug/l

0.12

184

(3006184) Hemoglobin [Mass/volume] in Capillary blood

903

0.87

0.56

1.8

2.1

131.73

127.91

g/l

0.72

641

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.43

0.56

1.1

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

169

1544

1.10

0.56

1.6

1.32

0.29

iu/ml

0.55

304

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

806

0.87

0.55

1.4

7.58

6.98

mmol/l

1.01

718

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.62

0.55

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

206

0.73

0.55

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

107

1.40

0.55

1.2

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

826

0.87

0.54

2.9

3.3

46.18

624.09

u/ml

1.14

744

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

125

1.36

0.53

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

295

1.22

0.52

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

874

1.12

0.52

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

111

1233

0.90

0.52

3.1

3.8

1.19

1.32

mmol/l

1.05

111

1212

(21494890) Protein electrophoresis panel - 24 hour Urine

348

0.80

0.51

2.0

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

126

1.35

0.51

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

344

3642

0.94

0.51

3.8

4.2

0.10

0.11

0.06

109

993

(3003740) Influenza virus B Ag [Presence] in Specimen

875

1.12

0.51

1.1

—

(1761868) Lipid panel - Serum or Plasma

1714

17515

0.97

0.51

2.4

2.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

278

1.22

0.51

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

206

1.26

0.50

1.2

1.4

139.92

129.15

nmol/l

0.92

206

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.46

0.50

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

498

0.84

0.49

1.2

1.5

—

(3017704) Immunofixation for Urine

180

1.28

0.49

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

207

1.26

0.49

1.3

1.6

—

(21494755) Public health laboratory ask at order entry panel

495

5178

0.95

0.49

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.52

0.48

5.1

4.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

851

1.12

0.48

1.3

135.44

113.37

u/ml

0.27

188

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

101

1121

0.90

0.47

3.6

3.0

1.22

1.51

ratio

—

103

(3019060) Gas panel - Arterial blood

213

2283

0.93

0.47

4.2

4.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.46

0.46

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.33

0.46

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

535

0.86

0.44

1.2

1.4

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

192

1.25

0.44

2.8

1.9

29.04

27.62

0.18

180

(3024932) HLA-DR beta [Type]

112

1.34

0.44

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

657

1.13

0.44

1.7

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

536

1.14

0.43

1.2

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

200

1869

1.07

0.43

7.9

24.39

24.34

mmol/l

0.08

190

1820

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

447

0.85

0.43

1.3

2.1

31.76

32.16

0.24

442

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

239

1.21

0.42

1.1

1.0

275.59

360.16

ng/l

0.93

171

(3042517) Benzodiazepines panel - Urine

1.43

0.42

1.3

2.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.56

0.42

1.0

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.63

0.42

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

369

1.17

0.41

2.5

1.9

15.93

14.31

0.49

356

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

669

0.88

0.41

1.1

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

450

4314

1.05

0.41

1.7

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

359

0.83

0.41

1.1

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

220

2067

1.07

0.41

2.7

3.0

130.90

127.29

g/l

1.92

214

2018

(3017958) Strawberry IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.06

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.00

0.41

0.0

1.3

—

1.18

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.06

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

337

0.83

0.41

2.0

2.1

2.50

2.44

u/field

0.01

144

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

605

1.13

0.40

1.1

—

(3001729) Color of Synovial fluid

1.47

0.40

3.8

1.5

—

(3050794) Legionella sp Ab [Presence] in Serum

1.47

0.40

1.4

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

389

1.16

0.40

1.3

1.2

1.80

1.46

u/ml

0.09

200

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

0.00

0.40

0.0

1.1

—

1.00

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.07

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.36

0.40

1.0

1.2

4.94

5.09

nmol/l

0.07

(44816559) Phosphatidylethanol [Mass/volume] in Blood

835

1.10

0.39

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.34

0.39

1.3

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

297

1.18

0.39

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

102

932

1.10

0.38

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

242

1.20

0.38

1.1

1.0

993.86

755.04

ng/l

1.63

168

(3035880) pH of Pleural fluid

148

0.74

0.38

1.1

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.36

0.38

1.1

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.33

0.37

1.1

1.0

0.03

1.06

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

408

3915

1.05

0.37

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

364

1.16

0.37

1.1

1.0

0.55

0.85

u/ml

0.49

(4281824) Cell count and differential, peritoneal fluid

757

0.90

0.37

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.35

0.37

1.8

2.3

—

(3024471) HLA-A [Type]

116

1.29

0.37

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

116

1.29

0.37

1.6

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

152

1.25

0.37

1.1

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

152

1.25

0.37

2.3

2.9

29.02

27.38

umol/l

0.22

114

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

120

1109

1.08

0.36

1.2

—

(3044927) Protein electrophoresis panel - Urine

384

1.15

0.36

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

139

1293

1.08

0.36

1.7

1.9

1.33

2.02

ug/l

0.75

119

1138

(44813793) Dust mix specific IgE antibody measurement

422

1.14

0.35

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

691

0.90

0.35

1.3

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

245

1.18

0.35

1.1

1.0

102.05

45.60

ng/l

0.40

175

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

125

0.72

0.35

1.7

1.6

—

103.66

—

(40765089) Chromosome analysis panel - Blood by G-banded

145

0.76

0.34

1.0

—

(3012565) Volume of 24 hour Urine

222

0.81

0.34

1.4

2.0

1642.22

1880.66

0.66

205

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

145

1.24

0.33

1.4

1.5

8.79

8.65

ug/l

0.08

145

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

109

1.29

0.33

2.3

2.1

15.29

16.33

umol/l

0.10

109

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

510

1.12

0.33

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

1063

0.92

0.33

3.2

4.1

3.69

3.79

mmol/l

1.82

1056

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

143

0.77

0.32

1.5

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

398

1.13

0.32

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

436

1.12

0.31

1.3

1.7

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

128

1.25

0.31

1.3

2.3

448.90

1028.94

e6/l

—

(3014271) Vancomycin [Susceptibility]

165

1.21

0.31

2.9

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

652

0.90

0.30

3.2

3.1

0.76

0.82

nmol/l

0.56

491

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

184

1.20

0.30

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

381

1.13

0.30

2.0

1.4

100454.52

91801.60

e6/l

0.04

251

(3023520) Reticulocytes [#/volume] in Blood

313

3007

1.04

0.29

2.6

2.5

65.46

71.76

e9/l

3.03

231

2211

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

910

0.92

0.29

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

107

0.75

0.29

1.5

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

108

1157

0.93

0.28

3.4

3.1

47.24

91.26

mg/l

0.42

936

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

108

1157

0.93

0.28

3.4

3.1

39.65

39.07

mg/l

0.02

933

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

814

1.08

0.28

4.6

4.9

1100.78

601.96

iu/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

232

1.16

0.28

1.1

—

(3024263) Appearance of Synovial fluid

204

1.18

0.28

1.9

1.4

—

(3004451) EKG impression Narrative

162

0.80

0.28

1.6

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

647

6307

1.03

0.28

2.0

1.8

—

(40765096) Chromosome analysis panel by Banding

103

1.26

0.28

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

242

1.16

0.28

1.3

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

806

1.08

0.27

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

322

3341

0.96

0.27

6.8

7.3

118.47

118.96

g/l

0.20

317

3242

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

318

1.13

0.27

1.1

1.3

1.61

1.63

g/l

0.20

318

(40768441) Liver Pathology biopsy report

356

1.12

0.27

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

150

0.80

0.27

4.0

4.3

—

(3045142) Bone marrow Pathology biopsy report

423

1.11

0.26

1.3

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

113

1.24

0.26

1.2

2.0

907.14

33814.22

e6/l

—

(3042733) HLA Ab [Presence] in Serum

104

1.25

0.26

3.1

4.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

583

0.91

0.26

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

925

1.07

0.26

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

141

1.21

0.26

1.0

2.2

—

2451.39

—

(3047189) Immunofixation for 24 hour Urine

160

0.81

0.26

2.8

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

235

0.85

0.25

1.7

1.8

1.60

2.76

u/field

0.60

159

(3007916) DNA double strand Ab [Titer] in Serum

1.23

0.25

1.2

1.5

—

260.21

—

(3003181) Sodium [Moles/volume] in Urine

752

1.08

0.25

1.5

1.4

63.76

63.86

mmol/l

0.01

599

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1.20

0.25

1.1

1.2

—

0.44

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

782

1.08

0.24

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.18

0.24

1.1

1.0

—

(3042631) Mycobacterium sp identified in Specimen

475

0.90

0.24

2.5

2.7

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

147

0.82

0.23

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

136

0.81

0.23

1.1

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.28

0.23

2.4

2.3

31.40

20.73

mg/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.28

0.23

3.2

9.7

6.38

5.07

mmol/l

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.22

0.22

1.2

1.0

0.02

0.39

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

357

0.90

0.21

1.3

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

70.08

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

38.18

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.1

—

3.75

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3002619) Bacteria identified in Specimen by Culture

103

0.78

0.21

1.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.16

0.21

7.2

9.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

151

1443

1.05

0.21

2.9

3.3

5811.91

617.60

u/ml

0.61

123

1225

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.21

0.0

2.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

364

1.10

0.20

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

102

1077

0.95

0.20

2.5

3.2

0.32

0.38

u/ml

1.19

608

(3020393) Adenovirus Ag [Presence] in Stool

1.22

0.20

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.20

0.19

1.8

2.4

1.00

0.78

u/field

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.18

0.19

1.2

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.18

0.19

1.0

1.1

—

4.21

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.18

0.19

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

520

1.08

0.19

1.3

1.2

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

433

1.09

0.19

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

433

1.09

0.19

1.4

—

(3036603) Volume of Urine

289

1.11

0.19

1.7

1.4

1837.81

1928.91

0.24

282

(3020650) Glucose [Presence] in Urine

132

0.83

0.18

1.5

1.4

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.21

0.18

2.4

2.0

0.95

1.45

mg/l

—

(3021788) Differential panel - Synovial fluid

775

1.06

0.18

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

756

1.06

0.17

2.2

2.4

34.67

62.30

ug/min

1.12

437

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

176

1.14

0.17

1.2

9.95

11.01

u/l

0.18

158

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

163

0.86

0.17

3.5

2.3

84.57

121.31

au/ml

—

(3033799) Differential panel - Peritoneal fluid

110

1.18

0.17

1.2

2.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.22

0.17

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

330

0.91

0.17

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

110

1151

0.95

0.17

1.4

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

205

1.12

0.17

2.3

2.5

219.75

155.93

umol/l

0.45

115

(3000330) Specific gravity of Urine by Test strip

228

2212

1.03

0.17

3.5

3.2

—

(3011648) Oxygen content in Venous blood

292

1.10

0.16

1.6

2.3

11.15

10.89

0.14

292

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

429

1.07

0.15

1.4

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

161

0.87

0.15

38.9

34.4

6.77

7.27

ug/l

0.47

146

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

554

0.94

0.15

1.3

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.08

0.14

2.3

1.5

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

150

0.87

0.14

3.5

2.3

162.23

161.00

nmol/l

0.02

129

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

148

1430

1.04

0.14

4.5

5.0

1.55

1.63

0.49

143

1329

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.78

0.14

4.7

4.2

41.29

64.05

u/l

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

147

1422

1.03

0.14

4.5

5.1

0.88

0.93

0.78

142

1328

(3023183) Ammonium ion [Moles/volume] in Plasma

685

1.05

0.13

2.2

2.7

31.23

33.11

umol/l

0.24

621

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

100

0.80

0.13

3.6

2.5

—

(21494434) Karyotype in Bone marrow

276

1.09

0.13

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

180

1.11

0.13

2.0

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

273

0.92

0.13

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

165

1698

0.97

0.12

1.7

1.8

—

(3021901) Oxygen saturation in Capillary blood

601

0.95

0.12

2.4

2.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

148

0.88

0.12

3.3

34.43

94.84

ng/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

747

1.04

0.12

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

336

1.07

0.12

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

905

0.96

0.12

1.7

1.5

—

(3034426) Prothrombin time (PT)

172

1.11

0.11

1.3

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

219

2239

0.98

0.11

7.7

7.9

93.76

94.11

0.24

219

2231

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.16

0.11

1.0

—

(3016502) Oxygen saturation in Arterial blood

348

3535

0.98

0.10

6.6

7.0

95.98

96.02

0.03

340

3399

(3012516) Albumin [Mass/volume] in Urine

1160

11515

1.01

0.10

3.2

717.80

444.42

mg/l

0.71

670

6654

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

1.13

0.09

2.2

3.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

106

1.13

0.09

2.2

3.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

207

0.92

0.09

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

114

0.88

0.09

1.2

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

757

0.96

0.09

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

773

1.04

0.09

1.1

125.32

120.28

0.86

686

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.11

0.09

3.3

7.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

1.09

0.08

1.0

0.04

0.64

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.09

0.08

1.0

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1215

12072

1.01

0.08

3.7

5.91

8.67

mg/mmol

1.92

690

7023

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.07

0.08

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.03

0.08

3.3

7.4

—

(3017569) Oxygen content in Arterial blood

144

0.90

0.08

1.2

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

369

0.95

0.08

2.3

2.8

7.27

43.60

mg/l

1.42

247

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.83

0.08

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

1617

1.02

0.08

1.8

1.7

1.62

1.54

g/l

0.39

139

1381

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

352

1.05

0.08

2.5

1.9

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

176

1.08

0.07

1.0

1.1

—

3.67

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

108

1.11

0.07

1.0

1.1

4.12

5.65

mg/g

1.71

102

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

224

2274

0.98

0.07

5.6

6.1

25.24

24.84

mmol/l

0.98

224

2262

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.83

0.07

1.6

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.06

0.07

1.2

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

226

1.06

0.06

1.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

295

1.05

0.06

1.2

1.6

1.36

1.08

promille

0.53

222

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

366

0.96

0.06

2.0

1.6

49.48

37.41

1.03

206

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

197

1.07

0.06

1.2

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

187

1898

0.98

0.06

9.1

8.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

217

1.06

0.06

3.2

2.5

43.77

45.85

0.22

137

(1761482) Bacteria [#/volume] in Urine by Culture

961

0.98

0.06

5.0

4.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

119

1.09

0.06

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

119

1.09

0.06

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

119

1.09

0.06

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

119

1.09

0.06

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

296

1.05

0.05

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

476

0.97

0.05

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

111

1089

1.02

0.05

1.6

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

748

0.98

0.05

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

273

0.95

0.05

1.1

1999.85

1549.76

miu/ml

0.92

273

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

747

0.98

0.05

2.3

2.0

0.78

0.80

nmol/l

0.11

634

(3047181) Lactate [Moles/volume] in Blood

118

1200

0.98

0.05

5.4

5.8

1.34

1.20

mmol/l

0.55

111

1053

(3003396) Base excess in Arterial blood by calculation

405

4081

0.99

0.05

6.4

6.5

1.15

1.12

mmol/l

0.06

339

3259

(3015183) Erythrocyte sedimentation rate

279

1.04

0.04

1.3

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

131

1.07

0.03

1.1

1.2

42.81

49.11

u/ml

0.20

126

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

250

1.04

0.03

1.0

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

406

4082

0.99

0.03

6.4

6.5

13.43

12.97

kpa

0.75

390

3887

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

429

1.03

0.03

1.3

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

300

1.03

0.03

1.2

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

102

1.08

0.03

1.0

1.1

—

222.86

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

651

0.98

0.02

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

172

1.05

0.02

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

369

0.98

0.02

1.1

1.04

1.05

ratio

0.50

135

(3009871) Measles virus Ab [Titer] in Serum

192

1.04

0.02

1.7

1.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

391

1.02

0.02

2.0

2.4

0.66

1.18

g/24h

0.94

187

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

519

0.98

0.02

1.7

1.6

46.60

53.57

0.66

314

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

117

0.94

0.01

1.0

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

407

4084

1.00

0.01

6.4

6.5

5.15

5.08

kpa

0.80

392

3895

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

513

1.01

0.01

1.3

1.2

31.41

24.02

u/l

0.21

437

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

104

1.06

0.01

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

154

1.04

0.00

3.9

3.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

264

1.02

0.00

9.0

11.7

851.81

847.42

nmol/l

0.02

255

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

274

1.02

0.00

13.2

17.3

1493.57

4985.60

nmol/l

0.50

264

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

105

1.05

0.00

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

292

0.99

0.00

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

155

1.03

0.00

1.9

2.6

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

221

2208

1.00

0.00

7.5

7.9

0.71

0.69

0.31

221

2194

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

1.03

0.00

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

156

1.03

0.00

1.1

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

103

0.97

0.00

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

304

0.99

0.00

1.7

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

183

0.98

0.00

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.96

0.00

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.88

0.00

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

0.94

0.00

1.0

1.3

—

(3008717) Parietal cell Ab [Titer] in Serum

0.00

0.0

1.0

—

438.89

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.96

-0.00

1.6

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

680

1.00

-0.00

1.1

145.96

13933.82

iu/ml

0.52

165

(3000285) Sodium [Moles/volume] in Blood

0.96

-0.00

1.4

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

260

1.00

-0.00

1.3

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.93

-0.00

1.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.07

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.95

-0.00

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.0

—

4.13

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.94

-0.00

3.6

2.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.92

-0.00

8.5

6.7

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.96

-0.00

1.2

1.1

—

(4034850) Laboratory test

152

1520

1.00

-0.00

11.0

8.8

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

2.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

19.80

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.91

-0.00

1.0

1.5

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

296.07

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

5.7

—

(3019174) dRVVT (LA screen)

0.86

-0.00

1.6

1.2

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.00

-0.00

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.93

-0.00

5.8

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_BREASTDISOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_BREASTDISOTH	1.077 [0.97, 1.19]	0.158
Birth year	1.0 [0.99, 1.01]	0.995

During the follow-up period (1.1.1998 — 31.12.2019), 1651 out of 19347 females with N14_BREASTDISOTH died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_BREASTDISOTH.

N-year risk	Females	Males
1	0.101%	No data
5	0.608%	No data
10	1.64%	No data
15	3.322%	No data
20	6.147%	No data

Relationships between endpoints

↥

Index endpoint: N14_BREASTDISOTH – Other disorders of breast

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of breast

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints